US20190218457A1 - Liquid-crystalline medium - Google Patents

Liquid-crystalline medium Download PDF

Info

Publication number
US20190218457A1
US20190218457A1 US16/364,475 US201916364475A US2019218457A1 US 20190218457 A1 US20190218457 A1 US 20190218457A1 US 201916364475 A US201916364475 A US 201916364475A US 2019218457 A1 US2019218457 A1 US 2019218457A1
Authority
US
United States
Prior art keywords
compounds
liquid
atoms
denotes
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/364,475
Inventor
Harald Hirschmann
Martina Windhorst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to US16/364,475 priority Critical patent/US20190218457A1/en
Publication of US20190218457A1 publication Critical patent/US20190218457A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • C09K19/44Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40 containing compounds with benzene rings directly linked
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/062Non-steroidal liquid crystal compounds containing one non-condensed benzene ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3028Cyclohexane rings in which at least two rings are linked by a carbon chain containing carbon to carbon single bonds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • C09K19/46Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40 containing esters
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/542Macromolecular compounds
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/133365Cells in which the active layer comprises a liquid crystalline polymer
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/136Liquid crystal cells structurally associated with a semi-conducting layer or substrate, e.g. cells forming part of an integrated circuit
    • G02F1/1362Active matrix addressed cells
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0448Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • C09K2019/121Compounds containing phenylene-1,4-diyl (-Ph-)
    • C09K2019/122Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/10Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings
    • C09K19/12Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
    • C09K2019/121Compounds containing phenylene-1,4-diyl (-Ph-)
    • C09K2019/123Ph-Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3004Cy-Cy
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3009Cy-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/301Cy-Cy-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3016Cy-Ph-Ph
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/08Non-steroidal liquid crystal compounds containing at least two non-condensed rings
    • C09K19/30Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
    • C09K19/3001Cyclohexane rings
    • C09K19/3003Compounds containing at least two rings in which the different rings are directly linked (covalent bond)
    • C09K2019/3027Compounds comprising 1,4-cyclohexylene and 2,3-difluoro-1,4-phenylene
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • C09K2019/3408Five-membered ring with oxygen(s) in fused, bridged or spiro ring systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/542Macromolecular compounds
    • C09K2019/548Macromolecular compounds stabilizing the alignment; Polymer stabilized alignment

Definitions

  • the present invention relates to a liquid-crystalline medium (LC medium), to the use thereof for electro-optical purposes, in particular for electro-optical displays having active-matrix addressing based on the ECB (electrically controlled birefringence) effect and for IPS (in-plane switching) displays or FFS (fringe field switching) displays, and to displays containing this medium.
  • LC medium liquid-crystalline medium
  • VAN vertical aligned nematic displays
  • MVA multi-domain vertical alignment
  • MVA multi-domain vertical alignment
  • PVA patterned vertical alignment, for example: Kim, Sang Soo, paper 15.4: “Super PVA Sets New State-of-the-Art for LCD-TV”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 760 to 763)
  • ASV advanced super view, for example: Shigeta, Mitzuhiro and Fukuoka, Hirofumi, paper 15.2: “Development of High Quality LCDTV”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp.
  • LC phases which have to satisfy a multiplicity of requirements.
  • Particularly important here are chemical resistance to moisture, air and physical influences, such as heat, infrared, visible and ultraviolet radiation and direct and alternating electric fields.
  • LC phases are required to have a liquid-crystalline mesophase in a suitable temperature range and low viscosity.
  • None of the hitherto-disclosed series of compounds having a liquid-crystalline mesophase includes a single compound which meets all these requirements. Mixtures of two to 25, preferably three to 18, compounds are therefore generally prepared in order to obtain substances which can be used as LC phases. However, it has not been possible to prepare optimum phases easily in this way since no liquid-crystal materials having significantly negative dielectric anisotropy and adequate long-term stability were hitherto available.
  • Matrix liquid-crystal displays are known.
  • Non-linear elements which can be used for individual switching of the individual pixels are, for example, active elements (i.e. transistors).
  • active matrix is then used, where a distinction can be made between two types:
  • the electro-optical effect used is usually dynamic scattering or the guest-host effect.
  • the use of single-crystal silicon as substrate material restricts the display size, since even modular assembly of various part-displays results in problems at the joints.
  • the electro-optical effect used is usually the TN effect.
  • TFTs comprising compound semiconductors, such as, for example, CdSe, or TFTs based on polycrystalline or amorphous silicon.
  • CdSe compound semiconductors
  • TFTs based on polycrystalline or amorphous silicon The latter technology is being worked on intensively worldwide.
  • the TFT matrix is applied to the inside of one glass plate of the display, while the other glass plate carries the transparent counterelectrode on its inside. Compared with the size of the pixel electrode, the TFT is very small and has virtually no adverse effect on the image.
  • This technology can also be extended to fully color-capable displays, in which a mosaic of red, green and blue filters is arranged in such a way that a filter element is opposite each switchable pixel.
  • MLC displays of this type are particularly suitable for TV applications (for example pocket TVs) or for high-information displays in automobile or aircraft construction.
  • TV applications for example pocket TVs
  • high-information displays in automobile or aircraft construction Besides problems regarding the angle dependence of the contrast and the response times, difficulties also arise in MLC displays due to insufficiently high specific resistance of the liquid-crystal mixtures [TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E., SORIMACHI, K., TAJIMA, E., WATANABE, H., SHIMIZU, H., Proc. Eurodisplay 84, September 1984: A 210-288 Matrix LCD Controlled by Double Stage Diode Rings, pp. 141 ff., Paris; STROMER, M., Proc.
  • VA displays have significantly better viewing-angle dependences and are therefore principally used for televisions and monitors.
  • frame rates image change frequency/refresh rate
  • the properties such as, for example, the low-temperature stability, must not be impaired at the same time.
  • An object of the invention is to provide liquid-crystal mixtures, in particular for monitor and TV applications, based on the ECB effect or on the IPS or FFS effect, which do not have the disadvantages indicated above, or only do so to a reduced extent.
  • liquid-crystalline media which simultaneously have a very low rotational viscosity and a high absolute value of the dielectric anisotropy as well as high reliability and high LTS. It is therefore possible to prepare liquid-crystal mixtures, preferably VA, IPS and FFS mixtures, which have very short response times, at the same time good phase properties and good low-temperature behavior.
  • the invention thus relates to a liquid-crystalline medium, preferably having negative dielectric anisotropy ( ⁇ ), which comprises a compound of the formula I1 and/or a compound of the formula I2, and one or more compounds of the formula EY,
  • the invention furthermore relates to an electro-optical display having active-matrix addressing, in particular based on the ECB, VA, PS-VA, PVA, PM-VA, SS-VA, PALC (plasma addressed liquid crystal), IPS, PS-IPS (polymer stabilized in-plane switching), FFS or PS-FFS effect, in particular on the UB-FFS (ultra brightness fringe field switching) or PS-FFS (polymer stabilized fringe field switching) effect, characterized in that it comprises, as dielectric, a liquid-crystalline medium as described above and below.
  • the liquid-crystalline media according to the invention preferably exhibit very broad nematic phase ranges with clearing points 68° C., preferably 70° C., very favorable values of the capacitive threshold, relatively high values of the holding ratio and at the same time very good low-temperature stabilities at ⁇ 20° C. and ⁇ 30° C., as well as low rotational viscosities and short response times.
  • the liquid-crystalline media according to the invention are furthermore distinguished by the fact that, in addition to the improvement in the rotational viscosity ⁇ 1, relatively high values of the elastic constants K33 for improving the response times can be observed.
  • an alkyl radical or alkoxy radical may be straight-chain or branched. It is preferably straight-chain, and preferably has 2, 3, 4, 5, 6 or 7 C atoms. Accordingly, preferred alkyl and alkoxy groups are ethyl, propyl, butyl, pentyl, hexyl, heptyl, ethoxy, propoxy, butoxy, pentoxy, hexoxy or heptoxy, furthermore methyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, methoxy, octoxy, nonoxy, decoxy, undecoxy, dodecoxy, tridecoxy or tetradedoxy.
  • An alkenyl radical may be straight-chain or branched. It is preferably straight-chain and has 2 to 10 C atoms. Accordingly, it denotes, in particular, vinyl, prop-1- or -2-enyl, but-1-, -2- or -3-enyl, pent-1-, -2-, -3- or -4-enyl, hex-1-, -2-, -3-, -4- or -5-enyl, hept-1-, -2-, -3-, -4-, -5- or -6-enyl, oct-1-, -2-, -3-, -4-, -5-, -6- or -7-enyl, non-1-, -2-, -3-, -4-, -5-, -6-, -7- or -8-enyl or dec-1-, -2-, -3-, -4-, -5-, -6-, -7-, -8-enyl or dec-1
  • an alkyl or alkenyl radical is at least monosubstituted by halogen
  • this radical is preferably straight-chain and halogen is preferably F or Cl.
  • halogen is preferably F.
  • the resultant radicals also include perfluorinated radicals.
  • the fluorine or chlorine substituent can be in any desired position, but is preferably in the w position.
  • alkenyl denotes vinyl, prop-1-enyl, prop-2-enyl or but-3-enyl.
  • the liquid-crystalline medium preferably comprises a compound of the formula I1 and a compound of the formula I2 as well as one or more compounds of the formula EY.
  • the compounds of the formulae I1 and I2 are preferably employed in the liquid-crystalline medium in amounts of 3% by weight, preferably 5% by weight, based on the mixture as a whole. Particular preference is given to liquid-crystalline media which comprise 5-30% by weight, very particularly preferably 10-20% by weight, of compounds of the formulae I1 and I2.
  • the compounds of the formula EY are preferably employed in the liquid-crystalline medium in amounts of 2% by weight, preferably 5% by weight, based on the mixture as a whole. Particular preference is given to liquid-crystalline media which comprise 3-20% by weight, very particularly preferably 5-15% by weight, of the compounds of the formula EY.
  • the total concentration of the compounds of the formulae I1, I2 and EY in the liquid-crystalline media according to the invention is preferably 10-35% by weight.
  • Liquid-crystalline medium which additionally comprises one or more compounds selected from the group of the compounds of the formulae IIA, IIB and IIC,
  • radicals Z 2 may have identical or different meanings on each occurrence.
  • radicals Z 2 and Z 2′ may each have identical or different meanings independently of one another and on each occurrence.
  • R 2A , R 2B and R 2C each preferably denote alkyl having 1-6 C atoms, in particular CH 3 , C 2 H 5 , n-C 3 H 7 , n-C 4 H 9 , or n-C 5 H 11 .
  • Z 2 and Z 2′ in the formulae IIA and IIB preferably each, independently of one another, denote a single bond, furthermore a —C 2 H 4 - or —CH 2 O— bridge.
  • (O)C v H 2v+1 preferably denotes OC v H 2v+1 , furthermore C v H 2v+1 .
  • (O)C v H 2v+1 preferably denotes C v H 2v+1 .
  • L 3 and L 4 preferably each denote F.
  • Particularly preferred mixtures according to the invention comprise one or more compounds selected from the formulae IIA-2, IIA-8, IIA-14, IIA-26, IIA-28, IIA-33, IIA-39, IIA-45, IIA-46, IIA-47, IIB-2, IIB-11, IIB-16 and IIC-1.
  • the proportion of compounds of the formulae IIA and/or IIB in the mixture as a whole is preferably at least 20% by weight.
  • Particularly preferred media according to the invention comprise at least one compound of the formula IIC-1,
  • Liquid-crystalline medium which additionally comprises one or more compounds of the formula III,
  • the medium according to the invention preferably comprises at least one compound of the formula IIIa and/or formula IIIb.
  • the proportion of compounds of the formula III in the mixture as a whole is preferably at least 5% by weight.
  • Liquid-crystalline medium which additionally comprises one or more tetracyclic compounds of the formulae
  • mixtures comprising at least one compound of the formula V-9.
  • Liquid-crystalline medium which additionally comprises one or more compounds of the formulae Y-1 to Y-6,
  • the medium according to the invention particularly preferably comprises one or more compounds of the formulae Y-1 to Y-6, preferably in amounts of ⁇ 5% by weight.
  • Liquid-crystalline medium additionally comprising one or more fluorinated terphenyls of the formulae T-1 to T-21,
  • R preferably denotes methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, pentoxy.
  • the medium according to the invention preferably comprises the terphenyls of the formulae T-1 to T-21 in amounts of 2-30% by weight, in particular 5-20% by weight.
  • R preferably denotes alkyl, furthermore alkoxy, each having 1-5 C atoms.
  • R preferably denotes alkyl or alkenyl, in particular alkyl.
  • R preferably denotes alkyl.
  • the terphenyls are preferably employed in the mixtures according to the invention if the ⁇ n value of the mixture is to be 0.1.
  • Preferred mixtures comprise 2-20% by weight of one or more terphenyl compounds selected from the group of the compounds T-1 to T-21. Particular preference is given to compounds of the formula T-4.
  • Liquid-crystalline medium additionally comprising one or more biphenyls of the formulae B-1 to B-4,
  • the proportion of the biphenyls of the formulae B-1 to B-4 in the mixture as a whole is preferably at least 3% by weight, in particular ⁇ 5% by weight.
  • the compounds of the formula B-2 are particularly preferred.
  • Liquid-crystalline medium comprising at least one compound of the formulae Z-1 to Z-7,
  • Liquid-crystalline medium comprising at least one compound of the formulae O-1 to O-17,
  • Preferred media comprise one or more compounds of the formulae O-1, O-3, O-4, O-5, O-9, O-12, O-14, O-15, O-16 and/or O-17.
  • Mixtures according to the invention very particularly preferably comprise the compounds of the formulae O-9, O-12, O-16 and/or O-17, in particular in amounts of 5-30%.
  • the medium according to the invention particularly preferably comprises the tricyclic compounds of the formula O-9a and/or of the formula O-9b in combination with one or more bicyclic compounds of the formulae O-17a and O-17b.
  • the total proportion of the compounds of the formulae O-9a and/or O-9b in combination with one or more compounds selected from the bicyclic compounds of the formulae O-17a and O-17b is preferably 5-40%, very particularly preferably 15-35%.
  • Very particularly preferred mixtures comprise the compounds O-9a and O-17a:
  • the compounds O-9a and O-17a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and especially preferably 18-22%, based on the mixture as a whole.
  • Very particularly preferred mixtures comprise the compounds O-9b and O-17a:
  • the compounds O-9b and O-17a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and especially preferably 18-22%, based on the mixture as a whole.
  • Very particularly preferred mixtures comprise the following three compounds:
  • the compounds O-9a, O-9b and O-17a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and especially preferably 18-22%, based on the mixture as a whole.
  • Preferred compounds of the formula O-17 are furthermore the compounds selected from the group of the compounds of the formulae
  • Preferred mixtures comprise 5-60% by weight, preferably 10-55% by weight, in particular 20-50% by weight, of the compound of the formula O-17e
  • Liquid-crystalline medium comprising one or more compounds of the formula BA
  • Preferred mixtures comprise one or more compounds selected from the group of compounds of formulae O-17e to O-17ij and BA-1 to BA-3.
  • Preferred liquid-crystalline media according to the invention comprise one or more substances which contain a tetrahydronaphthyl or naphthyl unit, such as, for example, the compounds of the formulae N-1 to N-5,
  • Preferred mixtures comprise one or more compounds selected from the group of the difluorodibenzochroman compounds of the formula BC, chromans of the formula CR, fluorinated phenanthrenes of the formulae PH-1 and PH-2, fluorinated dibenzofurans of the formulae BF-1 and BF-2, and fluorinated dibenzothiophenes of the formulae BS-1 and BS-2,
  • R B1 , R B2 , R CR1 , R CR2 , R 1 , R 2 each, independently of one another, have the meaning of R 2A in formula IIA.
  • c is 0, 1 or 2.
  • d is 1 or 2.
  • R 1 and R 2 preferably, independently of one another, denote alkyl, alkoxy, alkenyl or alkenyloxy having 1 to 6 or 2 to 6 C atoms respectively.
  • the mixtures according to the invention preferably comprise the compounds of the formulae BC, CR, PH-1, PH-2, BF-1, BF-2, BS-1 and/or BS-2 in amounts of 3 to 20% by weight, in particular in amounts of 3 to 15% by weight.
  • Particularly preferred compounds of the formulae BC, CR, BF and BS are the compounds BC-1 to BC-7, CR-1 to CR-5, BF-1a to BF-1d, and BS-1a to BS-1d,
  • mixtures comprising one, two or three compounds of the formulae BC-2 and/or BF-1a.
  • Preferred mixtures comprise one or more indane compounds of the formula In,
  • Preferred compounds of the formula In are the compounds of the formulae In-1 to In-16 indicated below:
  • the compounds of the formula In and the sub-formulae In-1 to In-16 are preferably employed in the mixtures according to the invention in concentrations 5% by weight, in particular 5-30% by weight and very particularly preferably 5-25% by weight.
  • Preferred mixtures additionally comprise one or more compounds of the formulae L-1 to L-11,
  • R, R 1 and R 2 each, independently of one another, have the meanings indicated for R 2A in claim 3 , (O) denotes an oxygen atom or a single bond, and alkyl denotes an alkyl radical having 1-6 C atoms. s denotes 1 or 2.
  • the compounds of the formulae L-1 to L-11 are preferably employed in concentrations of 5-50% by weight, in particular 5-40% by weight and very particularly preferably 10-40% by weight.
  • the medium comprises, with the exception of the polymerizable compounds, no compounds containing an alkenyl group.
  • the medium additionally comprises one or more compounds selected from the following formulae:
  • mixtures according to the invention preferably comprise
  • mixtures according to the invention which comprise the following mixture concepts:
  • the liquid-crystalline medium according to the invention preferably has a nematic phase from ⁇ 20° C. to ⁇ 70° C., particularly preferably from ⁇ 30° C. to ⁇ 80° C., very particularly preferably from ⁇ 40° C. to ⁇ 90° C.
  • the expression “have a nematic phase” here means on the one hand that no smectic phase and no crystallization are observed at low temperatures at the corresponding temperature and on the other hand that clearing still does not occur on heating from the nematic phase.
  • the investigation at low temperatures is carried out in a flow viscometer at the corresponding temperature and checked by storage in test cells having a layer thickness corresponding to the electro-optical use for at least 100 hours. If the storage stability at a temperature of ⁇ 20° C. in a corresponding test cell is 1000 h or more, the medium is referred to as stable at this temperature. At temperatures of ⁇ 30° C. and ⁇ 40° C., the corresponding times are 500 h and 250 h respectively. At high temperatures, the clearing point is measured by conventional methods in capillaries.
  • the liquid-crystal mixture preferably has a nematic phase range of at least 60 K and a flow viscosity v 20 of at most 30 mm 2 ⁇ s ⁇ 1 at 20° C.
  • the values of the birefringence ⁇ n in the liquid-crystal mixture are generally between 0.07 and 0.16, preferably between 0.08 and 0.13.
  • the liquid-crystal mixture according to the invention has a ⁇ of ⁇ 0.5 to ⁇ 8.0, in particular ⁇ 2.5 to ⁇ 6.0, where Ac denotes the dielectric anisotropy.
  • the rotational viscosity ⁇ 1 at 20° C. is preferably ⁇ 150 mPa ⁇ s, in particular ⁇ 130 mPa ⁇ s.
  • the liquid-crystal media according to the invention have relatively small values for the threshold voltage (V 0 ). They are preferably in the range from 1.7 V to 3.0 V, particularly preferably ⁇ 2.5 V and very particularly preferably ⁇ 2.3 V.
  • threshold voltage relates to the capacitive threshold (V 0 ), also known as the Freedericks threshold, unless explicitly indicated otherwise.
  • liquid-crystal media according to the invention have high values for the voltage holding ratio in liquid-crystal cells.
  • liquid-crystal media having a low addressing voltage or threshold voltage exhibit a lower voltage holding ratio than those having a higher addressing voltage or threshold voltage and vice versa.
  • dielectrically positive compounds denotes compounds having a ⁇ >1.5
  • dielectrically neutral compounds denotes those where ⁇ 1.5 ⁇ 1.5
  • dielectrically negative compounds denotes those having ⁇ 1.5.
  • the dielectric anisotropy of the compounds is determined here by dissolving 10% of the compounds in a liquid-crystalline host and determining the capacitance of the resultant mixture in at least one test cell in each case having a layer thickness of 20 ⁇ m with homeotropic and with homogeneous surface alignment at 1 kHz.
  • the measurement voltage is typically 0.5 V to 1.0 V, but is always lower than the capacitive threshold of the respective liquid-crystal mixture investigated.
  • the mixtures according to the invention are suitable for all VA-TFT applications, such as, for example, VAN, MVA, (S)-PVA ((super)-patterned vertical alignment), ASV, PSA (polymer sustained VA), SS (surface-stabilized) -VA and PS-VA (polymer stabilized VA). They are furthermore suitable for IPS (in-plane switching) and FFS (fringe field switching), in particular UB-FFS, having negative Ac.
  • the nematic liquid-crystal mixtures in the displays according to the invention generally comprise two components A and B, which themselves consist of one or more individual compounds.
  • Component A has significantly negative dielectric anisotropy and gives the nematic phase a dielectric anisotropy of ⁇ 0.5.
  • it preferably comprises one or more compounds of the formulae IIA, IIB and/or IIC, furthermore one or more compounds of the formula III.
  • the proportion of component A is preferably between 45 and 100%, in particular between 60 and 100%.
  • one (or more) individual compound(s) which has (have) a value of ⁇ 0.8 is (are) preferably selected. This value must be more negative, the smaller the proportion A in the mixture as a whole.
  • Component B has pronounced nematogeneity and a flow viscosity of not greater than 30 mm 2 ⁇ s ⁇ 1 , preferably not greater than 25 mm 2 ⁇ s ⁇ 1 , at 20° C.
  • Particularly preferred individual compounds in component B are extremely low-viscosity nematic liquid crystals having a flow viscosity of not greater than 18 mm 2 ⁇ s ⁇ 1 , preferably not greater than 12 mm 2 ⁇ s ⁇ 1 , at 20° C.
  • Component B is monotropically or enantiotropically nematic, has no smectic phases and is able to prevent the occurrence of smectic phases down to very low temperatures in liquid-crystal mixtures. For example, if various materials of high nematogeneity are in each case added to a smectic liquid-crystal mixture, the nematogeneity of these materials can be compared through the degree of suppression of smectic phases that is achieved.
  • the mixture may optionally also comprise a component C, comprising compounds having a dielectric anisotropy of ⁇ 1.5.
  • component C comprising compounds having a dielectric anisotropy of ⁇ 1.5.
  • positive compounds are generally present in a mixture of negative dielectric anisotropy in amounts of 20% by weight, based on the mixture as a whole.
  • the mixture according to the invention comprises one or more compounds having a dielectric anisotropy of ⁇ 1.5, these are preferably one or more compounds of the formulae P-1 and/or P-2,
  • the compounds of the formulae P-1 and/or P-2 are preferably employed in the mixtures according to the invention in concentrations of 0.5-10% by weight, in particular 0.5-8% by weight.
  • liquid-crystal phases may also comprise more than 18 components, preferably 18 to 25 components.
  • the phases preferably comprise 4 to 15, in particular 5 to 12, and particularly preferably ⁇ 10, compounds of the formulae IIA, IIB and/or IIC and optionally III.
  • the other constituents are preferably selected from nematic or nematogenic substances, in particular known substances, from the classes of the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl or cyclohexyl benzoates, phenyl or cyclohexyl cyclohexanecarboxylates, phenylcyclohexanes, cyclohexylbiphenyls, cyclohexylcyclohexanes, cyclohexylnaphthalenes, 1,4-biscyclohexylbiphenyls or cyclohexylpyrimidines, phenyl- or cyclohexyldioxanes, optionally halogenated stilbenes, benzyl phenyl ethers, tolans and substituted cinnamic acid esters.
  • L and E each denote a carbo- or heterocyclic ring system from the group formed by 1,4-disubstituted benzene and cyclohexane rings, 4,4′-disubstituted biphenyl, phenylcyclohexane and cyclohexylcyclohexane systems, 2,5-disubstituted pyrimidine and 1,3-dioxane rings, 2,6-disubstituted naphthalene, di- and tetrahydronaphthalene, quinazoline and tetrahydroquinazoline, G denotes —CH ⁇ CH— —N(O) ⁇ N—
  • R 20 and R 21 are different from one another, for example, one of these radicals usually being an alkyl or alkoxy group.
  • Other variants of the proposed substituents are also common. Many such substances or also mixtures thereof are commercially available. All these substances can be prepared by methods known from the literature.
  • VA, IPS or FFS mixture according to the invention may also comprise compounds in which, for example, H, N, O, Cl and F have been replaced by the corresponding isotopes.
  • Polymerizable compounds so-called reactive mesogens (RMs), for example as disclosed in U.S. Pat. No. 6,861,107, may furthermore be added to the mixtures according to the invention in concentrations of preferably 0.01-5% by weight, particularly preferably 0.2-2% by weight, based on the mixture.
  • These mixtures may optionally also comprise an initiator, as described, for example, in U.S. Pat. No. 6,781,665.
  • the initiator for example Irganox-1076 from BASF, is preferably added to the mixture comprising polymerizable compounds in amounts of 0-1%.
  • PS-VA polymer-stabilized VA
  • PSA polymer sustained alignment
  • the polymerization is preferably carried out under the following conditions: the polymerizable components are polymerized in a cell using a UV-A lamp of defined intensity for a defined period and applied voltage (typically 10 to 30 V alternating voltage, frequencies in the range from 60 Hz to 1 kHz).
  • the UV-A light source employed is typically a metal-halide vapor lamp or high-pressure mercury lamp having an intensity of 50 mW/cm 2 .
  • n 2, 3, 4, 5 or 6, do not polymerize.
  • the polymerizable compounds are selected from the compounds of the formula M
  • Particularly preferred compounds of the formula M are those in which
  • Suitable and preferred RMs for use in liquid-crystalline media and PS-VA displays or PSA displays according to the invention are selected, for example, from the following formulae:
  • Suitable polymerizable compounds are listed, for example, in Table D.
  • the liquid-crystalline media in accordance with the present application preferably comprise in total 0.1 to 10%, preferably 0.2 to 4.0%, particularly preferably 0.2 to 2.0%, of polymerizable compounds.
  • the mixtures according to the invention may furthermore comprise conventional additives, such as, for example, stabilizers, antioxidants, UV absorbers, nanoparticles, microparticles, etc.
  • the structure of the liquid-crystal displays according to the invention corresponds to the usual geometry, as described, for example, in EP-A 0 240 379, hereby incorporated by reference.
  • the cyclohexylene rings are trans-1,4-cyclohexylene rings.
  • n, m, m′ and z each, independently of one another, denote 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12, preferably 1, 2, 3, 4, 5 or 6, and (O) denotes an oxygen atom or a single bond.
  • Table 1 the ring elements of the respective compound are coded, in Table 2 the bridging members are listed, and in Table 3 the meanings of the symbols for the left-hand or righthand side chains of the compounds are indicated.
  • the mixtures according to the invention preferably comprise one or more of the compounds from Table A indicated below.
  • liquid-crystal mixtures which can be used in accordance with the invention are prepared in a manner which is conventional per se.
  • the desired amount of the components used in lesser amount is dissolved in the components making up the principal constituent, advantageously at elevated temperature. It is also possible to mix solutions of the components in an organic solvent, for example in acetone, chloroform or methanol, and to remove the solvent again, for example by distillation, after thorough mixing.
  • liquid-crystal phases according to the invention can be modified in such a way that they can be employed in any type of, for example, ECB, VAN, IPS, GH (guest-host) or ASM-VA (axially symmetric microdomain-vertically aligned)LCD display that has been disclosed to date.
  • the dielectrics may also comprise further additives known to the person skilled in the art and described in the literature, such as, for example, UV absorbers, antioxidants, nanoparticles and free-radical scavengers.
  • further additives known to the person skilled in the art and described in the literature, such as, for example, UV absorbers, antioxidants, nanoparticles and free-radical scavengers.
  • UV absorbers for example, UV absorbers, antioxidants, nanoparticles and free-radical scavengers.
  • 0-15% of pleochroic dyes, stabilizers or chiral dopants may be added.
  • Suitable stabilizers for the mixtures according to the invention are, in particular, those listed in Table B.
  • pleochroic dyes furthermore conductive salts, preferably ethyldimethyldodecylammonium 4-hexoxybenzoate, tetrabutylammonium tetraphenylboranate or complex salts of crown ethers (cf., for example, Haller et al., Mol. Cryst. Liq. Cryst., Volume 24, pages 249-258 (1973)), may be added in order to improve the conductivity or substances may be added in order to modify the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases. Substances of this type are described, for example, in DE-A 22 09 127, 22 40 864, 23 21 632, 23 38 281, 24 50 088, 26 37 430 and 28 53 728.
  • Table B shows possible dopants which are generally added to the mixtures according to the invention.
  • the mixtures preferably comprise 0-10% by weight, in particular 0.01-5% by weight and particularly preferably 0.01-3% by weight of dopants. If the mixtures comprise only one dopant, is is em- ployed in amounts of 0.01-4% by weight, preferable 0.1-1.0% by weight.
  • the medium according to the invention particularly preferably comprises Tinuvin® 770 (bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate), preferably in amounts of 0.001-5% by weight, based on the liquid-crystalline medium.
  • Tinuvin® 770 bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate
  • Table D shows example compounds which can preferably be used as reactive mesogenic compounds in the LC media in accordance with the present invention. If the mixtures according to the invention comprise one or more reactive compounds, they are preferably employed in amounts of 0.01-5% by weight. It may also be necessary to add an initiator or a mixture of two or more initiators for the polymerization. The initiator or initiator mixture is preferably added in amounts of 0.001-2% by weight, based on the mixture.
  • a suitable initiator is, for example, Irgacure (BASF) or Irganox (BASF).
  • the mixtures according to the invention comprise one or more polymerizable compounds, preferably selected from the polymerizable compounds of the formulae RM-1 to RM-121.
  • Media of this type are suitable, in particular, for PS-FFS and PS-IPS applications.
  • compounds RM-1, RM-2, RM-3, RM-4, RM-5, RM-9, RM-17, RM-42, RM-48, RM-68, RM-87, RM-91, RM-98, RM-99 and RM-101 are particularly preferred.
  • the reactive mesogens or the polymerizable compounds of the formula M and of the formulae RM-1 to RM-121 are furthermore suitable as stabilizers.
  • the polymerizable compounds are not polymerized, but instead are added to the liquid-crystalline medium in concentrations >1%.
  • m.p. denotes the melting point and C denotes the clearing point of a liquid-crystalline substance in degrees Celsius; boiling temperatures are denoted by b.p. Furthermore:
  • C denotes crystalline solid state
  • S denotes smectic phase (the index denotes the phase type)
  • N denotes nematic state
  • Ch denotes cholesteric phase
  • I denotes isotropic phase
  • Tg denotes glass-transition temperature. The number between two symbols indicates the conversion temperature in degrees Celsius.
  • the host mixture used for determination of the optical anisotropy ⁇ n of the compounds of the formula I is the commercial mixture ZLI-4792 (Merck KGaA).
  • the dielectric anisotropy ⁇ is determined using commercial mixture ZLI-2857.
  • the physical data of the compound to be investigated are obtained from the change in the dielectric constants of the host mixture after addition of the compound to be investigated and extrapolation to 100% of the compound employed. In general, 10% of the compound to be investigated are dissolved in the host mixture, depending on the solubility.
  • parts or percent data denote parts by weight or percent by weight.
  • the display used for measurement of the threshold voltage has two plane-parallel outer plates at a separation of 20 ⁇ m and electrode layers with alignment layers comprising SE-1211 (Nissan Chemicals) on top on the insides of the outer plates, which effect a homeotropic alignment of the liquid crystals.
  • CY-3-O2 12.00% Clearing point [° C.]: 74.0 CY-3-O4 10.00% ⁇ n [589 nm, 20° C.]: 0.1064 CCY-3-O2 6.00% ⁇ [1 kHz, 20° C.]: ⁇ 3.2 CCY-4-O2 6.50% ⁇ ⁇ [1 kHz, 20° C.]: 3.8 CCH-34 9.00% K 1 [pN, 20° C.]: 13.7 CCH-35 5.00% K 3 [pN, 20° C.]: 13.6 CCP-3-1 14.50% ⁇ 1 [mPa ⁇ s, 20° C.]: 119 CCP-3-3 11.00% V 0 [20° C., V]: 2.19 PYP-2-3 9.00% PYP-2-4 8.00% Y-4O-O4 9.00%
  • CY-3-O2 12.00% Clearing point [° C.]: 73.5 CY-3-O4 10.00% ⁇ n [589 nm, 20° C.]: 0.1065 CCY-3-O2 6.00% ⁇ [1 kHz, 20° C.]: ⁇ 3.3 CCY-4-O2 5.50% ⁇ ⁇ [1 kHz, 20° C.]: 3.8 CCH-34 8.50% K 1 [pN, 20° C.]: 13.9 CCH-35 5.00% K 3 [pN, 20° C.]: 13.9 CCP-3-1 15.00% ⁇ 1 [mPa ⁇ s, 20° C.]: 119 CCP-3-3 11.50% V 0 [20° C., V]: 2.18 PYP-2-3 5.50% PYP-2-4 5.00% PP-1-3 2.00% PGIY-2-O4 5.00% Y-4O-O4 9.00%
  • the mixtures according to Examples P39 and P40 are preferably suitable for PS-VA applications, in particular 2D and 3D TV applications.
  • the mixtures according to Examples M1 to M9 and P1 to P40 may additionally be stabilized with one or two stabilizers selected from the group of compounds a) to h) mentioned below, where the stabilizer is in each case added in amounts of 0.01-0.04%, based on the mixture.

Abstract

The invention relates to a liquid-crystalline medium and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PM-VA, SS-VA, PALC, IPS, PS-IPS, FFS or PS-FFS effect.

Description

  • The present invention relates to a liquid-crystalline medium (LC medium), to the use thereof for electro-optical purposes, in particular for electro-optical displays having active-matrix addressing based on the ECB (electrically controlled birefringence) effect and for IPS (in-plane switching) displays or FFS (fringe field switching) displays, and to displays containing this medium.
  • The principle of electrically controlled birefringence, the ECB effect or also DAP (deformation of aligned phases) effect, was described for the first time in 1971 (M. F. Schieckel and K. Fahrenschon, “Deformation of nematic liquid crystals with vertical orientation in electrical fields”, Appl. Phys. Lett. 19 (1971), 3912). This was followed by papers by J. F. Kahn (Appl. Phys. Lett. 20 (1972), 1193) and G. Labrunie and J. Robert (J. Appl. Phys. 44 (1973), 4869).
  • The papers by J. Robert and F. Clerc (SID 80 Digest Techn. Papers (1980), 30), J. Duchene (Displays 7 (1986), 3) and H. Schad (SID 82 Digest Techn. Papers (1982), 244) showed that liquid-crystalline phases must have high values for the ratio of the elastic constants K3/K1, high values for the optical anisotropy Δn and values for the dielectric anisotropy of Δε≤−0.5 in order to be suitable for use in high-information display elements based on the ECB effect. Electro-optical display elements based on the ECB effect have a homeotropic edge alignment (VA technology=vertically aligned). Dielectrically negative liquid-crystal media can also be used in displays which use the so-called IPS or FFS effect.
  • Displays which use the ECB effect, as so-called VAN (vertically aligned nematic) displays, for example in the MVA (multi-domain vertical alignment, for example: Yoshide, H. et al., paper 3.1: “MVA LCD for Notebook or Mobile PCs . . . ”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book I, pp. 6 to 9, and Liu, C. T. et al., paper 15.1: “A 46-inch TFT-LCD HDTV Technology . . . ”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 750 to 753), PVA (patterned vertical alignment, for example: Kim, Sang Soo, paper 15.4: “Super PVA Sets New State-of-the-Art for LCD-TV”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 760 to 763), ASV (advanced super view, for example: Shigeta, Mitzuhiro and Fukuoka, Hirofumi, paper 15.2: “Development of High Quality LCDTV”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 754 to 757) modes, have established themselves as one of the three more recent types of liquid-crystal display that are currently the most important, in particular for television applications, besides IPS (in-plane switching) displays (for example: Yeo, S. D., paper 15.3: “An LC Display for the TV Application”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book II, pp. 758 & 759) and the long-known TN (twisted nematic) displays. The technologies are compared in general form, for example, in Souk, Jun, SID Seminar 2004, seminar M-6: “Recent Advances in LCD Technology”, Seminar Lecture Notes, M-6/1 to M-6/26, and Miller, Ian, SID Seminar 2004, seminar M-7: “LCD-Television”, Seminar Lecture Notes, M-7/1 to M-7/32. Although the response times of modern ECB displays have already been significantly improved by addressing methods with overdrive, for example: Kim, Hyeon Kyeong et al., paper 9.1: “A 57-in. Wide UXGA TFT-LCD for HDTV Application”, SID 2004 International Symposium, Digest of Technical Papers, XXXV, Book I, pp. 106 to 109, the achievement of video-compatible response times, in particular on switching of grey shades, is still a problem which has not yet been satisfactorily solved.
  • Industrial application of this effect in electro-optical display elements requires LC phases, which have to satisfy a multiplicity of requirements. Particularly important here are chemical resistance to moisture, air and physical influences, such as heat, infrared, visible and ultraviolet radiation and direct and alternating electric fields.
  • Furthermore, industrially usable LC phases are required to have a liquid-crystalline mesophase in a suitable temperature range and low viscosity.
  • None of the hitherto-disclosed series of compounds having a liquid-crystalline mesophase includes a single compound which meets all these requirements. Mixtures of two to 25, preferably three to 18, compounds are therefore generally prepared in order to obtain substances which can be used as LC phases. However, it has not been possible to prepare optimum phases easily in this way since no liquid-crystal materials having significantly negative dielectric anisotropy and adequate long-term stability were hitherto available.
  • Matrix liquid-crystal displays (MLC displays) are known. Non-linear elements which can be used for individual switching of the individual pixels are, for example, active elements (i.e. transistors). The term “active matrix” is then used, where a distinction can be made between two types:
    • 1. MOS (metal oxide semiconductor) transistors on a silicon wafer as substrate
    • 2. thin-film transistors (TFTs) on a glass plate as substrate.
  • In the case of type 1, the electro-optical effect used is usually dynamic scattering or the guest-host effect. The use of single-crystal silicon as substrate material restricts the display size, since even modular assembly of various part-displays results in problems at the joints.
  • In the case of the more promising type 2, which is preferred, the electro-optical effect used is usually the TN effect.
  • A distinction is made between two technologies: TFTs comprising compound semiconductors, such as, for example, CdSe, or TFTs based on polycrystalline or amorphous silicon. The latter technology is being worked on intensively worldwide.
  • The TFT matrix is applied to the inside of one glass plate of the display, while the other glass plate carries the transparent counterelectrode on its inside. Compared with the size of the pixel electrode, the TFT is very small and has virtually no adverse effect on the image. This technology can also be extended to fully color-capable displays, in which a mosaic of red, green and blue filters is arranged in such a way that a filter element is opposite each switchable pixel.
  • The term MLC displays here covers any matrix display with integrated non-linear elements, i.e., besides the active matrix, also displays with passive elements, such as varistors or diodes (MIM=metal-insulatormetal).
  • MLC displays of this type are particularly suitable for TV applications (for example pocket TVs) or for high-information displays in automobile or aircraft construction. Besides problems regarding the angle dependence of the contrast and the response times, difficulties also arise in MLC displays due to insufficiently high specific resistance of the liquid-crystal mixtures [TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E., SORIMACHI, K., TAJIMA, E., WATANABE, H., SHIMIZU, H., Proc. Eurodisplay 84, September 1984: A 210-288 Matrix LCD Controlled by Double Stage Diode Rings, pp. 141 ff., Paris; STROMER, M., Proc. Eurodisplay 84, September 1984: Design of Thin Film Transistors for Matrix Addressing of Television Liquid Crystal Displays, pp. 145 ff., Paris]. With decreasing resistance, the contrast of an MLC display deteriorates. Since the specific resistance of the liquid-crystal mixture generally drops over the life of an MLC display owing to interaction with the inside surfaces of the display, a high (initial) resistance is very important for displays that have to have acceptable resistance values over a long operating period.
  • There is thus still a great demand for MLC displays having fast response times at the same time as a large working-temperature range and a low threshold voltage, with the aid of which various grey shades can be generated.
  • The disadvantages of the MLC-TN displays frequently used is, due to their comparatively low contrast, the relatively high viewing-angle dependence and the difficulty of generating grey shades in these displays.
  • VA displays have significantly better viewing-angle dependences and are therefore principally used for televisions and monitors. However, there continues to be a need to improve the response times here, in particular in view of use for televisions having frame rates (image change frequency/refresh rate) of greater than 60 Hz. However, the properties, such as, for example, the low-temperature stability, must not be impaired at the same time.
  • An object of the invention is to provide liquid-crystal mixtures, in particular for monitor and TV applications, based on the ECB effect or on the IPS or FFS effect, which do not have the disadvantages indicated above, or only do so to a reduced extent. In particular, it must be ensured for monitors and televisions that the liquid-crystal mixtures also work at extremely high and extremely low temperatures and at the same time have very short response times and at the same time have improved reliability behavior, in particular exhibit no or significantly reduced image sticking after long operating times.
  • Surprisingly, it is possible to reduce the ratio of rotational viscosity γ1 and the elastic constant K33 (γ1/K33) and thus to improve the response times, and at the same time to achieve high reliability and low-temperature stability (LTS), if a compound of the formulae I1 and I2 below and one or more compounds of the formula EY below are in each case used in liquid-crystal mixtures, in particular in LC mixtures having negative dielectric anisotropy, preferably for VA, IPS and FFS displays, furthermore for PM (passive matrix)-VA displays.
  • Surprisingly, the combination of the compounds of the formulae I1 and I2 with the compounds of the formula EY results in liquid-crystalline media which simultaneously have a very low rotational viscosity and a high absolute value of the dielectric anisotropy as well as high reliability and high LTS. It is therefore possible to prepare liquid-crystal mixtures, preferably VA, IPS and FFS mixtures, which have very short response times, at the same time good phase properties and good low-temperature behavior.
  • The invention thus relates to a liquid-crystalline medium, preferably having negative dielectric anisotropy (Δε), which comprises a compound of the formula I1 and/or a compound of the formula I2, and one or more compounds of the formula EY,
  • Figure US20190218457A1-20190718-C00001
  • in which the individual radicals each, independently of one another, and identically or differently on each occurrence, have one of the following meanings:
    • R1 and R1* denote H, an alkyl or alkenyl radical having up to 15 C atoms which is unsubstituted, monosubstituted by CN or CF3 or at least monosubstituted by halogen, where, in addition, one or more CH2 groups in these radicals may each be replaced by —O—, —S—,
  • Figure US20190218457A1-20190718-C00002
  • —C≡C—, —CF2O—, —OCF2—, —OC—O— or —O—CO— in such a way that O atoms are not linked directly to one another, or a cycloalkyl ring having 3 to 6 C atoms,
    • L1 and L2 denote F, Cl, CF3 or CHF2, preferably F,
      with the proviso that the LC medium does not comprise a compound of the formula I3,
  • Figure US20190218457A1-20190718-C00003
  • The invention furthermore relates to an electro-optical display having active-matrix addressing, in particular based on the ECB, VA, PS-VA, PVA, PM-VA, SS-VA, PALC (plasma addressed liquid crystal), IPS, PS-IPS (polymer stabilized in-plane switching), FFS or PS-FFS effect, in particular on the UB-FFS (ultra brightness fringe field switching) or PS-FFS (polymer stabilized fringe field switching) effect, characterized in that it comprises, as dielectric, a liquid-crystalline medium as described above and below.
  • The liquid-crystalline media according to the invention preferably exhibit very broad nematic phase ranges with clearing points 68° C., preferably 70° C., very favorable values of the capacitive threshold, relatively high values of the holding ratio and at the same time very good low-temperature stabilities at −20° C. and −30° C., as well as low rotational viscosities and short response times. The liquid-crystalline media according to the invention are furthermore distinguished by the fact that, in addition to the improvement in the rotational viscosity γ1, relatively high values of the elastic constants K33 for improving the response times can be observed.
  • In the formulae above and below, an alkyl radical or alkoxy radical may be straight-chain or branched. It is preferably straight-chain, and preferably has 2, 3, 4, 5, 6 or 7 C atoms. Accordingly, preferred alkyl and alkoxy groups are ethyl, propyl, butyl, pentyl, hexyl, heptyl, ethoxy, propoxy, butoxy, pentoxy, hexoxy or heptoxy, furthermore methyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, methoxy, octoxy, nonoxy, decoxy, undecoxy, dodecoxy, tridecoxy or tetradedoxy.
  • Oxaalkyl preferably denotes straight-chain 2-oxapropyl (=methoxymethyl), 2-(=ethoxymethyl) or 3-oxabutyl (=2-methoxyethyl), 2-, 3- or 4-oxapentyl, 2-, 3-, 4- or 5-oxahexyl, 2-, 3-, 4-, 5- or 6-oxaheptyl, 2-, 3-, 4-, 5-, 6-, or 7-oxaoctyl, 2-, 3-, 4-, 5-, 6-, 7- or 8-oxanonyl or 2-, 3-, 4-, 5-, 6-, 7-, 8- or 9-oxadexyl.
  • An alkenyl radical may be straight-chain or branched. It is preferably straight-chain and has 2 to 10 C atoms. Accordingly, it denotes, in particular, vinyl, prop-1- or -2-enyl, but-1-, -2- or -3-enyl, pent-1-, -2-, -3- or -4-enyl, hex-1-, -2-, -3-, -4- or -5-enyl, hept-1-, -2-, -3-, -4-, -5- or -6-enyl, oct-1-, -2-, -3-, -4-, -5-, -6- or -7-enyl, non-1-, -2-, -3-, -4-, -5-, -6-, -7- or -8-enyl or dec-1-, -2-, -3-, -4-, -5-, -6-, -7-, -8- or -9-enyl.
  • If an alkyl or alkenyl radical is at least monosubstituted by halogen, this radical is preferably straight-chain and halogen is preferably F or Cl. In the case of polysubstitution, halogen is preferably F. The resultant radicals also include perfluorinated radicals. In the case of monosubstitution, the fluorine or chlorine substituent can be in any desired position, but is preferably in the w position.
  • Particular preference is given to compounds in which “alkenyl” denotes vinyl, prop-1-enyl, prop-2-enyl or but-3-enyl.
  • Some preferred embodiments of the mixtures according to the invention are given below.
  • The liquid-crystalline medium preferably comprises a compound of the formula I1 and a compound of the formula I2 as well as one or more compounds of the formula EY.
  • The compounds of the formulae I1 and I2 are preferably employed in the liquid-crystalline medium in amounts of 3% by weight, preferably 5% by weight, based on the mixture as a whole. Particular preference is given to liquid-crystalline media which comprise 5-30% by weight, very particularly preferably 10-20% by weight, of compounds of the formulae I1 and I2.
  • The compounds of the formula EY are preferably employed in the liquid-crystalline medium in amounts of 2% by weight, preferably 5% by weight, based on the mixture as a whole. Particular preference is given to liquid-crystalline media which comprise 3-20% by weight, very particularly preferably 5-15% by weight, of the compounds of the formula EY.
  • The total concentration of the compounds of the formulae I1, I2 and EY in the liquid-crystalline media according to the invention is preferably 10-35% by weight.
  • In the compounds of the formula EY, R1 and R1* preferably denote alkoxy having 2, particularly preferably 2 to 6, C atoms and L1=L2=F.
  • Particular preference is given to compounds of the formula EY selected from the group consisting of the following sub-formulae:
  • Figure US20190218457A1-20190718-C00004
    Figure US20190218457A1-20190718-C00005
    Figure US20190218457A1-20190718-C00006
  • Particular preference is given to compounds of the formulae EY1-EY14. Very particular preference is given to compounds of the formula EY9.
  • Further preferred embodiments of the liquid-crystalline medium according to the invention are indicated below:
  • a) Liquid-crystalline medium which additionally comprises one or more compounds selected from the group of the compounds of the formulae IIA, IIB and IIC,
  • Figure US20190218457A1-20190718-C00007
  • in which
      • R2A, R2B and R2C each, independently of one another, denote H, an alkyl or alkenyl radical having up to 15 C atoms which is unsubstituted, monosubstituted by CN or CF3 or at least monosubstituted by halogen, where, in addition, one or more CH2 groups in these radicals may each be replaced by —O—, —S—,
  • Figure US20190218457A1-20190718-C00008
      •  —C≡C—, —CF2O—, —OCF2—, —OC—O— or —O—CO— in such a way that O atoms are not linked directly to one another, or a cycloalkyl ring having 3 to 6 C atoms,
      • L1-4 each, independently of one another, denote F, Cl, CF3 or CHF2,
      • Z2 and Z2′ each, independently of one another, denote a single bond, —CH2CH2—, —CH═CH—, —CF2O—, —OCF2—, —CH2O—, —OCH2—, —COO—, —OCO—, —C2F4—, —CF═CF—, or —CH═CHCH2O—,
      • p denotes 1 or 2,
      • q denotes 0 or 1,
      • v denotes an integer from 1 to 6, and
      • (O) denotes an oxygen atom or a single bond.
  • In the compounds of the formulae IIA and IIB, the radicals Z2 may have identical or different meanings on each occurrence. In the compounds of the formula IIB, the radicals Z2 and Z2′ may each have identical or different meanings independently of one another and on each occurrence.
  • In the compounds of the formulae IIA, IIB and IIC, R2A, R2B and R2C each preferably denote alkyl having 1-6 C atoms, in particular CH3, C2H5, n-C3H7, n-C4H9, or n-C5H11.
  • In the compounds of the formulae IIA and IIB, L1, L2, L3 and L4 preferably denote L1=L2=F and L3=L4=F, furthermore L1=F and L2=Cl, L1=CI and L2=F, L3=F and L4=Cl, L3=CI and L4=F. Z2 and Z2′ in the formulae IIA and IIB preferably each, independently of one another, denote a single bond, furthermore a —C2H4- or —CH2O— bridge.
  • If in the formula IIB Z2═—C2H4— or —CH2O—, Z2′ is preferably a single bond or, if Z2′=—C2H4- or —CH2O—, Z2 is preferably a single bond. In the compounds of the formulae IIA and IIB, (O)CvH2v+1 preferably denotes OCvH2v+1, furthermore CvH2v+1. In the compounds of the formula IIC, (O)CvH2v+1 preferably denotes CvH2v+1. In the compounds of the formula IIC, L3 and L4 preferably each denote F.
  • Preferred compounds of the formulae IIA, IIB and IIC are indicated below:
  • Figure US20190218457A1-20190718-C00009
    Figure US20190218457A1-20190718-C00010
    Figure US20190218457A1-20190718-C00011
    Figure US20190218457A1-20190718-C00012
    Figure US20190218457A1-20190718-C00013
    Figure US20190218457A1-20190718-C00014
    Figure US20190218457A1-20190718-C00015
      • in which alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, alkenyl denotes a straight-chain alkenyl radical having 2-6 C atoms, and (O) denotes an oxygen atom or a single bond.
  • Particularly preferred mixtures according to the invention comprise one or more compounds selected from the formulae IIA-2, IIA-8, IIA-14, IIA-26, IIA-28, IIA-33, IIA-39, IIA-45, IIA-46, IIA-47, IIB-2, IIB-11, IIB-16 and IIC-1.
  • The proportion of compounds of the formulae IIA and/or IIB in the mixture as a whole is preferably at least 20% by weight.
  • Particularly preferred media according to the invention comprise at least one compound of the formula IIC-1,
  • Figure US20190218457A1-20190718-C00016
      • in which alkyl and alkyl* have the meanings indicated above, preferably in amounts of >3% by weight, in particular >5% by weight and particularly preferably 5-25% by weight.
  • b) Liquid-crystalline medium which additionally comprises one or more compounds of the formula III,
  • Figure US20190218457A1-20190718-C00017
  • in which
      • R31 and R32 each, independently of one another, denote a straight-chain alkyl, alkoxyalkyl or alkoxy radical having up to 12 C atoms,
  • Figure US20190218457A1-20190718-C00018
  • denotes
  • Figure US20190218457A1-20190718-C00019
  • and
      • Z3 denotes a single bond, —CH2CH2—, —CH═CH—, —CF2O—, —OCF2 , —CH2O—, —OCH2−, —COO—, —OCO—, —C2F4—, —C4H8−, or —CF═CF—.
  • Preferred compounds of the formula III are indicated below:
  • Figure US20190218457A1-20190718-C00020
  • in which
      • alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms.
  • The medium according to the invention preferably comprises at least one compound of the formula IIIa and/or formula IIIb.
  • The proportion of compounds of the formula III in the mixture as a whole is preferably at least 5% by weight.
  • c) Liquid-crystalline medium which additionally comprises one or more tetracyclic compounds of the formulae
  • Figure US20190218457A1-20190718-C00021
  • in which
      • R7-10 each, independently of one another, have one of the meanings indicated for R2A in formula IIA,
      • w and x each, independently of one another, denote an integer from 1 to 6, and
      • (O) denotes an oxygen atom or a single bond.
  • Particular preference is given to mixtures comprising at least one compound of the formula V-9.
  • d) Liquid-crystalline medium which additionally comprises one or more compounds of the formulae Y-1 to Y-6,
  • Figure US20190218457A1-20190718-C00022
      • in which R14-R19 each, independently of one another, denotes an alkyl or alkoxy radical having 1-6 C atoms, and z and m each, independently of one another, denote an integer from 1 to 6.
  • The medium according to the invention particularly preferably comprises one or more compounds of the formulae Y-1 to Y-6, preferably in amounts of ≥5% by weight.
  • e) Liquid-crystalline medium additionally comprising one or more fluorinated terphenyls of the formulae T-1 to T-21,
  • Figure US20190218457A1-20190718-C00023
    Figure US20190218457A1-20190718-C00024
    Figure US20190218457A1-20190718-C00025
  • in which
      • R denotes a straight-chain alkyl or alkoxy radical having 1-7 C atoms or alkenyl having 2-7 C atoms, (O) denotes an oxygen atom or a single bond, and m=0, 1, 2, 3, 4, 5 or 6 and n denotes 0, 1, 2, 3 or 4.
  • R preferably denotes methyl, ethyl, propyl, butyl, pentyl, hexyl, methoxy, ethoxy, propoxy, butoxy, pentoxy.
  • The medium according to the invention preferably comprises the terphenyls of the formulae T-1 to T-21 in amounts of 2-30% by weight, in particular 5-20% by weight.
  • Particular preference is given to compounds of the formulae T-1, T-2, T-20 and T-21. In these compounds, R preferably denotes alkyl, furthermore alkoxy, each having 1-5 C atoms. In the compounds of the formula T-20, R preferably denotes alkyl or alkenyl, in particular alkyl. In the compound of the formula T-21, R preferably denotes alkyl.
  • The terphenyls are preferably employed in the mixtures according to the invention if the Δn value of the mixture is to be 0.1. Preferred mixtures comprise 2-20% by weight of one or more terphenyl compounds selected from the group of the compounds T-1 to T-21. Particular preference is given to compounds of the formula T-4.
  • f) Liquid-crystalline medium additionally comprising one or more biphenyls of the formulae B-1 to B-4,
  • Figure US20190218457A1-20190718-C00026
  • in which
      • alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms,
      • alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms, and
      • alkoxy denotes a straight-chain alkoxy radical having 1-6 C atoms.
  • The proportion of the biphenyls of the formulae B-1 to B-4 in the mixture as a whole is preferably at least 3% by weight, in particular ≥5% by weight.
  • Of the compounds of the formulae B-1 to B-4, the compounds of the formula B-2 are particularly preferred.
  • Particularly preferred biphenyls are
  • Figure US20190218457A1-20190718-C00027
      • in which alkyl* denotes an alkyl radical having 1-6 C atoms. The medium according to the invention particularly preferably comprises one or more compounds of the formulae B-1a and/or B-2c.
  • g) Liquid-crystalline medium comprising at least one compound of the formulae Z-1 to Z-7,
  • Figure US20190218457A1-20190718-C00028
  • in which
      • R denotes a straight-chain alkyl or alkoxy radical having 1-7 C atoms or an alkenyl radical having 2-7 C atoms,
      • alkyl denotes an alkyl radical having 1-6 C atoms, and
      • (O) alkyl denotes alkyl or Oalkyl.
  • h) Liquid-crystalline medium comprising at least one compound of the formulae O-1 to O-17,
  • Figure US20190218457A1-20190718-C00029
    Figure US20190218457A1-20190718-C00030
      • in which R1 and R2 have the meanings indicated for R2A in formula IIA and the compounds of the formula O-17 are not identical with the compounds of the formulae I1 and I2. R1 and R2 preferably each, independently of one another, denote straight-chain alkyl having 1-6 C atoms or R1 denotes straight-chain alkyl having 1-6 C atoms and R2 denotes alkenyl having 2-6 C atoms.
  • Preferred media comprise one or more compounds of the formulae O-1, O-3, O-4, O-5, O-9, O-12, O-14, O-15, O-16 and/or O-17.
  • Mixtures according to the invention very particularly preferably comprise the compounds of the formulae O-9, O-12, O-16 and/or O-17, in particular in amounts of 5-30%.
  • Preferred compounds of the formulae O-9 and O-17 are indicated below:
  • Figure US20190218457A1-20190718-C00031
  • The medium according to the invention particularly preferably comprises the tricyclic compounds of the formula O-9a and/or of the formula O-9b in combination with one or more bicyclic compounds of the formulae O-17a and O-17b. The total proportion of the compounds of the formulae O-9a and/or O-9b in combination with one or more compounds selected from the bicyclic compounds of the formulae O-17a and O-17b is preferably 5-40%, very particularly preferably 15-35%.
  • Very particularly preferred mixtures comprise the compounds O-9a and O-17a:
  • Figure US20190218457A1-20190718-C00032
  • The compounds O-9a and O-17a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and especially preferably 18-22%, based on the mixture as a whole.
  • Very particularly preferred mixtures comprise the compounds O-9b and O-17a:
  • Figure US20190218457A1-20190718-C00033
  • The compounds O-9b and O-17a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and especially preferably 18-22%, based on the mixture as a whole.
  • Very particularly preferred mixtures comprise the following three compounds:
  • Figure US20190218457A1-20190718-C00034
  • The compounds O-9a, O-9b and O-17a are preferably present in the mixture in a concentration of 15-35%, particularly preferably 15-25% and especially preferably 18-22%, based on the mixture as a whole.
  • Preferred compounds of the formula O-17 are furthermore the compounds selected from the group of the compounds of the formulae
  • Figure US20190218457A1-20190718-C00035
      • preferably in each case in amounts of 3% by weight, in particular ≥10% by weight.
  • Preferred mixtures comprise 5-60% by weight, preferably 10-55% by weight, in particular 20-50% by weight, of the compound of the formula O-17e
  • Figure US20190218457A1-20190718-C00036
  • Preference is furthermore given to liquid-crystalline mixtures which comprise the compound O-17e
  • Figure US20190218457A1-20190718-C00037
  • and the compound O-17j
  • Figure US20190218457A1-20190718-C00038
  • preferably in total amounts of 3-60% by weight.
  • i) Liquid-crystalline medium comprising one or more compounds of the formula BA
  • Figure US20190218457A1-20190718-C00039
  • in which
      • alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-12 C atoms,
  • Figure US20190218457A1-20190718-C00040
  • denotes
  • Figure US20190218457A1-20190718-C00041
  • and
      • Z3 denotes a single bond, —CH2CH2—, —CH═CH—, —CF2O—, —OCF2—, —CH2O—, —OCH2—, —COO—, —OCO—, —C2F4—, —C4H8—, or —CF═CF—.
  • Preferred compounds of the formula BA are indicated below:
  • Figure US20190218457A1-20190718-C00042
  • Preferred mixtures comprise one or more compounds selected from the group of compounds of formulae O-17e to O-17ij and BA-1 to BA-3.
  • j) Preferred liquid-crystalline media according to the invention comprise one or more substances which contain a tetrahydronaphthyl or naphthyl unit, such as, for example, the compounds of the formulae N-1 to N-5,
  • Figure US20190218457A1-20190718-C00043
      • in which R1N and R2N each, independently of one another, have the meanings indicated for R2A in formula IIA, preferably denote straight-chain alkyl, straight-chain alkoxy or straight-chain alkenyl, and
      • Z1 and Z2 each, independently of one another,
        • denote —C2H4—, —CH═CH—, —(CH2)4—, —(CH2)3O—, —O(CH2)3—, —CH═CHCH2CH2—, —CH2CH2CH═CH—, —CH2O—, —OCH2—, —COO—, —OCO—, —C2F4—, —CF═CF—, —CF═CH—, —CH═CF—, —CF2O—, —OCF2—, —CH2— or a single bond.
  • k) Preferred mixtures comprise one or more compounds selected from the group of the difluorodibenzochroman compounds of the formula BC, chromans of the formula CR, fluorinated phenanthrenes of the formulae PH-1 and PH-2, fluorinated dibenzofurans of the formulae BF-1 and BF-2, and fluorinated dibenzothiophenes of the formulae BS-1 and BS-2,
  • Figure US20190218457A1-20190718-C00044
  • in which
  • RB1, RB2, RCR1, RCR2, R1, R2 each, independently of one another, have the meaning of R2A in formula IIA. c is 0, 1 or 2. d is 1 or 2. R1 and R2 preferably, independently of one another, denote alkyl, alkoxy, alkenyl or alkenyloxy having 1 to 6 or 2 to 6 C atoms respectively.
  • The mixtures according to the invention preferably comprise the compounds of the formulae BC, CR, PH-1, PH-2, BF-1, BF-2, BS-1 and/or BS-2 in amounts of 3 to 20% by weight, in particular in amounts of 3 to 15% by weight.
  • Particularly preferred compounds of the formulae BC, CR, BF and BS are the compounds BC-1 to BC-7, CR-1 to CR-5, BF-1a to BF-1d, and BS-1a to BS-1d,
  • Figure US20190218457A1-20190718-C00045
    Figure US20190218457A1-20190718-C00046
    Figure US20190218457A1-20190718-C00047
  • in which
      • alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, and
      • alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms, and
      • alkenyloxy denotes a straight-chain alkenyloxy radical having 2-6 C atoms.
  • Very particular preference is given to mixtures comprising one, two or three compounds of the formulae BC-2 and/or BF-1a.
  • I) Preferred mixtures comprise one or more indane compounds of the formula In,
  • Figure US20190218457A1-20190718-C00048
  • in which
      • R11, R12,
      • R13 each, independently of one another, denote a straight-chain alkyl, alkoxy, alkoxyalkyl or alkenyl radical having 1-6 C atoms or 2-6 C atoms respectively,
      • R12 and R13 additionally denote halogen, preferably F,
  • Figure US20190218457A1-20190718-C00049
  • denotes
  • Figure US20190218457A1-20190718-C00050
      • i denotes 0, 1 or 2.
  • Preferred compounds of the formula In are the compounds of the formulae In-1 to In-16 indicated below:
  • Figure US20190218457A1-20190718-C00051
    Figure US20190218457A1-20190718-C00052
  • Particular preference is given to the compounds of the formulae In-1, In-2, In-3 and In-4.
  • The compounds of the formula In and the sub-formulae In-1 to In-16 are preferably employed in the mixtures according to the invention in concentrations 5% by weight, in particular 5-30% by weight and very particularly preferably 5-25% by weight.
  • m) Preferred mixtures additionally comprise one or more compounds of the formulae L-1 to L-11,
  • Figure US20190218457A1-20190718-C00053
    Figure US20190218457A1-20190718-C00054
  • in which
  • R, R1 and R2 each, independently of one another, have the meanings indicated for R2A in claim 3, (O) denotes an oxygen atom or a single bond, and alkyl denotes an alkyl radical having 1-6 C atoms. s denotes 1 or 2.
  • Particular preference is given to the compounds of the formulae L-1 and L-4, in particular L-4.
  • The compounds of the formulae L-1 to L-11 are preferably employed in concentrations of 5-50% by weight, in particular 5-40% by weight and very particularly preferably 10-40% by weight.
  • n) The medium comprises, with the exception of the polymerizable compounds, no compounds containing an alkenyl group.
  • o) The medium additionally comprises one or more compounds selected from the following formulae:
  • Figure US20190218457A1-20190718-C00055
      • In the compounds of the formulae Q-1 to Q-9, RQ and XQ each, independently of one another, have the meanings of R2A in formula IIA. RQ and XQ preferably denote a straight-chain alkyl radical having 1-6 C atoms, in particular having 2-5 C atoms.
  • Particularly preferred mixture concepts are indicated below: (the acronyms used are explained in Tables 1-3 and in Table A. n and m here each, independently of one another, denote 1-6).
  • The mixtures according to the invention preferably comprise
      • PYP-n-m, in particular PYP-2-3 and/or PYP-2-4,
      • preferably in concentrations >5%, in particular 8-30%, based on the mixture as a whole, and/or
      • CPY-n-Om, in particular CPY-2-O2, CPY-3-O2 and/or CPY-5-O2, preferably in concentrations >5%, in particular 10-30%, based on the mixture as a whole, and/or
      • B-nO-Om, preferably in concentrations of 1-15, and/or
      • CY-n-Om, preferably CY-3-O2, CY-3-O4, CY-5-O2 and/or CY-5-O4, preferably in concentrations >5%, in particular 15-50%, based on the mixture as a whole, and/or
      • CCY-n-Om, preferably CCY-4-O2, CCY-3-O2, CCY-3-O3, CCY-3-O1 and/or CCY-5-O2, preferably in concentrations >5%, in particular 10-30%, based on the mixture as a whole, and/or
      • CLY-n-Om, preferably CLY-2-O4, CLY-3-O2 and/or CLY-3-O3, preferably in concentrations >5%, in particular 10-30%, based on the mixture as a whole, and/or
      • CK-n-F, preferably CK-3-F, CK-4-F and/or CK-5-F, preferably >5%, in particular 5-25%, based on the mixture as a whole.
  • Preference is furthermore given to mixtures according to the invention which comprise the following mixture concepts:
  • (n and m each, independently of one another, denote 1-6.)
      • CPY-n-Om and CY-n-Om, preferably in concentrations of 10-80%, based on the mixture as a whole, and/or
      • CPY-n-Om and CK-n-F, preferably in concentrations of 10-70%, based on the mixture as a whole, and/or
      • CPY-n-Om and PY-n-Om, preferably CPY-2-O2 and/or CPY-3-O2 and PY-3-O2, preferably in concentrations of 10-40%, based on the mixture as a whole, and/or
      • CPY-n-Om and CLY-n-Om, preferably in concentrations of 10-80%, based on the mixture as a whole, and/or
      • CC-3-V1, preferably in amounts of 3-15% and/or
      • CC-V-V, preferably in amounts of 5-60% and/or
      • CC-3-V, preferably in amounts of 5-60% and/or
      • PGIY-n-Om, preferably in amounts of 3-15%, and/or
      • CC-n-2V1, preferably in amounts of 3-20%.
  • The liquid-crystalline medium according to the invention preferably has a nematic phase from ≤−20° C. to ≥70° C., particularly preferably from ≤−30° C. to ≥80° C., very particularly preferably from ≤−40° C. to ≥90° C.
  • The expression “have a nematic phase” here means on the one hand that no smectic phase and no crystallization are observed at low temperatures at the corresponding temperature and on the other hand that clearing still does not occur on heating from the nematic phase. The investigation at low temperatures is carried out in a flow viscometer at the corresponding temperature and checked by storage in test cells having a layer thickness corresponding to the electro-optical use for at least 100 hours. If the storage stability at a temperature of −20° C. in a corresponding test cell is 1000 h or more, the medium is referred to as stable at this temperature. At temperatures of −30° C. and −40° C., the corresponding times are 500 h and 250 h respectively. At high temperatures, the clearing point is measured by conventional methods in capillaries.
  • The liquid-crystal mixture preferably has a nematic phase range of at least 60 K and a flow viscosity v20 of at most 30 mm2·s−1 at 20° C.
  • The values of the birefringence Δn in the liquid-crystal mixture are generally between 0.07 and 0.16, preferably between 0.08 and 0.13.
  • The liquid-crystal mixture according to the invention has a Δε of −0.5 to −8.0, in particular −2.5 to −6.0, where Ac denotes the dielectric anisotropy. The rotational viscosity γ1 at 20° C. is preferably ≤150 mPa·s, in particular ≤130 mPa·s.
  • The liquid-crystal media according to the invention have relatively small values for the threshold voltage (V0). They are preferably in the range from 1.7 V to 3.0 V, particularly preferably ≤2.5 V and very particularly preferably ≤2.3 V.
  • For the present invention, the term “threshold voltage” relates to the capacitive threshold (V0), also known as the Freedericks threshold, unless explicitly indicated otherwise.
  • In addition, the liquid-crystal media according to the invention have high values for the voltage holding ratio in liquid-crystal cells.
  • In general, liquid-crystal media having a low addressing voltage or threshold voltage exhibit a lower voltage holding ratio than those having a higher addressing voltage or threshold voltage and vice versa.
  • For the present invention, the term “dielectrically positive compounds” denotes compounds having a Δε>1.5, the term “dielectrically neutral compounds” denotes those where −1.5≤Δε≤1.5 and the term “dielectrically negative compounds” denotes those having Δε<−1.5. The dielectric anisotropy of the compounds is determined here by dissolving 10% of the compounds in a liquid-crystalline host and determining the capacitance of the resultant mixture in at least one test cell in each case having a layer thickness of 20 μm with homeotropic and with homogeneous surface alignment at 1 kHz. The measurement voltage is typically 0.5 V to 1.0 V, but is always lower than the capacitive threshold of the respective liquid-crystal mixture investigated.
  • All temperature values indicated for the present invention are in ° C.
  • The mixtures according to the invention are suitable for all VA-TFT applications, such as, for example, VAN, MVA, (S)-PVA ((super)-patterned vertical alignment), ASV, PSA (polymer sustained VA), SS (surface-stabilized) -VA and PS-VA (polymer stabilized VA). They are furthermore suitable for IPS (in-plane switching) and FFS (fringe field switching), in particular UB-FFS, having negative Ac.
  • The nematic liquid-crystal mixtures in the displays according to the invention generally comprise two components A and B, which themselves consist of one or more individual compounds.
  • Component A has significantly negative dielectric anisotropy and gives the nematic phase a dielectric anisotropy of −0.5. Besides one or more compounds of the formulae I1, I2 and EY, it preferably comprises one or more compounds of the formulae IIA, IIB and/or IIC, furthermore one or more compounds of the formula III.
  • The proportion of component A is preferably between 45 and 100%, in particular between 60 and 100%.
  • For component A, one (or more) individual compound(s) which has (have) a value of Δε≤−0.8 is (are) preferably selected. This value must be more negative, the smaller the proportion A in the mixture as a whole.
  • Component B has pronounced nematogeneity and a flow viscosity of not greater than 30 mm2·s−1, preferably not greater than 25 mm2·s−1, at 20° C.
  • A multiplicity of suitable materials is known to the person skilled in the art from the literature. Particular preference is given to compounds of the formula III.
  • Particularly preferred individual compounds in component B are extremely low-viscosity nematic liquid crystals having a flow viscosity of not greater than 18 mm2·s−1, preferably not greater than 12 mm2·s−1, at 20° C.
  • Component B is monotropically or enantiotropically nematic, has no smectic phases and is able to prevent the occurrence of smectic phases down to very low temperatures in liquid-crystal mixtures. For example, if various materials of high nematogeneity are in each case added to a smectic liquid-crystal mixture, the nematogeneity of these materials can be compared through the degree of suppression of smectic phases that is achieved.
  • The mixture may optionally also comprise a component C, comprising compounds having a dielectric anisotropy of Δε≥1.5. These so-called positive compounds are generally present in a mixture of negative dielectric anisotropy in amounts of 20% by weight, based on the mixture as a whole.
  • If the mixture according to the invention comprises one or more compounds having a dielectric anisotropy of Δε≥1.5, these are preferably one or more compounds of the formulae P-1 and/or P-2,
  • Figure US20190218457A1-20190718-C00056
  • in which
    • R denotes straight-chain alkyl, alkoxy or alkenyl, each having 1 or 2 to 6 C atoms respectively, and
    • X denotes F, Cl, CF3, OCF3, OCHFCF3 or CCF2CHFCF3, preferably F or OCF3.
  • The compounds of the formulae P-1 and/or P-2 are preferably employed in the mixtures according to the invention in concentrations of 0.5-10% by weight, in particular 0.5-8% by weight.
  • Particular preference is given to the compound of the formula
  • Figure US20190218457A1-20190718-C00057
  • which is preferably employed in amounts of 0.5-3% by weight.
  • In addition, these liquid-crystal phases may also comprise more than 18 components, preferably 18 to 25 components.
  • Besides one or more compounds of the formula I, the phases preferably comprise 4 to 15, in particular 5 to 12, and particularly preferably <10, compounds of the formulae IIA, IIB and/or IIC and optionally III.
  • Besides compounds of the formulae I1, I2 and EY and the compounds of the formulae IIA, IIB and/or IIC and optionally III, other constituents may also be present, for example in an amount of up to 45% of the mixture as a whole, but preferably up to 35%, in particular up to 10%.
  • The other constituents are preferably selected from nematic or nematogenic substances, in particular known substances, from the classes of the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl or cyclohexyl benzoates, phenyl or cyclohexyl cyclohexanecarboxylates, phenylcyclohexanes, cyclohexylbiphenyls, cyclohexylcyclohexanes, cyclohexylnaphthalenes, 1,4-biscyclohexylbiphenyls or cyclohexylpyrimidines, phenyl- or cyclohexyldioxanes, optionally halogenated stilbenes, benzyl phenyl ethers, tolans and substituted cinnamic acid esters.
  • The most important compounds which are suitable as constituents of liquid-crystal phases of this type can be characterized by the formula IV,

  • R20-L-G-E-R21  IV
  • in which L and E each denote a carbo- or heterocyclic ring system from the group formed by 1,4-disubstituted benzene and cyclohexane rings, 4,4′-disubstituted biphenyl, phenylcyclohexane and cyclohexylcyclohexane systems, 2,5-disubstituted pyrimidine and 1,3-dioxane rings, 2,6-disubstituted naphthalene, di- and tetrahydronaphthalene, quinazoline and tetrahydroquinazoline,
    G denotes —CH═CH— —N(O)═N—
      • —CH═CQ- —CH═N(O)—
      • —C≡C— —CH2—CH2
      • —CO—O— —CH2—O—
      • —CO-S— —CH2—S—
      • —CH═N— —COO-Phe-COO—
      • —CF2O— —CF═CF—
      • —OCF2— —OCH2
      • —(CH2)4— —(CH2)3O—
        or a C—C single bond, Phe denotes phenylene, Q denotes halogen, preferably chlorine, or —CN, and R20 and R21 each denote alkyl, alkenyl, alkoxy, alkoxyalkyl or alkoxycarbonyloxy having up to 18, preferably up to 8, carbon atoms, or one of these radicals alternatively denotes CN, NC, NO2, NCS, CF3, SF5, OCF3, F, CI or Br.
  • In most of these compounds, R20 and R21 are different from one another, for example, one of these radicals usually being an alkyl or alkoxy group. Other variants of the proposed substituents are also common. Many such substances or also mixtures thereof are commercially available. All these substances can be prepared by methods known from the literature.
  • It goes without saying for the person skilled in the art that the VA, IPS or FFS mixture according to the invention may also comprise compounds in which, for example, H, N, O, Cl and F have been replaced by the corresponding isotopes.
  • Polymerizable compounds, so-called reactive mesogens (RMs), for example as disclosed in U.S. Pat. No. 6,861,107, may furthermore be added to the mixtures according to the invention in concentrations of preferably 0.01-5% by weight, particularly preferably 0.2-2% by weight, based on the mixture. These mixtures may optionally also comprise an initiator, as described, for example, in U.S. Pat. No. 6,781,665. The initiator, for example Irganox-1076 from BASF, is preferably added to the mixture comprising polymerizable compounds in amounts of 0-1%. Mixtures of this type can be used for so-called polymer-stabilized VA (PS-VA) modes or PSA (polymer sustained alignment) modes, in which polymerization of the reactive mesogens is intended to take place in the liquid-crystalline mixture. The prerequisite for this is that the liquid-crystal mixture itself comprises no polymerizable components which likewise polymerize under the conditions where the compounds of the formula M polymerize.
  • The polymerization is preferably carried out under the following conditions: the polymerizable components are polymerized in a cell using a UV-A lamp of defined intensity for a defined period and applied voltage (typically 10 to 30 V alternating voltage, frequencies in the range from 60 Hz to 1 kHz). The UV-A light source employed is typically a metal-halide vapor lamp or high-pressure mercury lamp having an intensity of 50 mW/cm2. These are conditions where, for example, liquid-crystalline compounds containing an alkenyl or alkenyloxy side chain, such as, for example, the compounds of the formula
  • Figure US20190218457A1-20190718-C00058
  • where n=2, 3, 4, 5 or 6,
    do not polymerize.
  • In a preferred embodiment of the invention, the polymerizable compounds are selected from the compounds of the formula M

  • RMa-AM1-(ZM1-AM2)m1-RMb  M
  • in which the individual radicals have the following meaning:
    • RMa and RMb each, independently of one another, denote P, P-Sp-, H, F, Cl, Br, I, —CN, —NO2, —NCO, —NCS, —OCN, —SCN, SF5 or straight-chain or branched alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH2 groups may each be replaced, independently of one another, by —C(R0)═C(R00)—, —C≡C—, —N(R00)—, —O—, —S—, —CO—, —CO—O—, —O—CO—, or —O—CO—O— in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may each be replaced by F, Cl, Br, I, CN, P or P-Sp-, where at least one of the radicals RMa and RMb preferably denotes or contains a group P or P-Sp-, for example, RMa and RMb each, independently of one another, denote P, P-Sp-, H, halogen, SF5, NO2, an alkyl, alkenyl or alkynyl group, where at least one of the radicals RMa and RMb preferably denotes or contains a group P or P-Sp-,
    • P denotes a polymerizable group,
    • Sp denotes a spacer group or a single bond,
    • AM1 and AM2 each, independently of one another, denote an aromatic, heteroaromatic, alicyclic or heterocyclic group, preferably having 4 to 25 ring atoms, preferably C atoms, which also includes or may contain annellated rings, and which may optionally be mono- or polysubstituted by L,
    • L denotes P, P-Sp-, OH, CH2OH, F, Cl, Br, I, —CN, —NO2, —NCO, —NCS, —OCN, —SCN, —C(═O)N(Rx)2, —C(═O)Y1, —C(═O)Rx, —N(Rx)2, optionally substituted silyl, optionally substituted aryl having 6 to 20 C atoms, or straight-chain or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 25 C atoms, in which, in addition, one or more H atoms may each be replaced by F, Cl, P or P-Sp-, preferably P, P-Sp-, H, OH, CH2OH, halogen, SF5, NO2, an alkyl, alkenyl or alkynyl group,
    • Y1 denotes halogen,
    • ZM1 denotes —O—, —S—, —CO—, —CO—O—, —OCO—, —O—CO—O—, —OCH2—, —CH2O—, —SCH2—, —CH2S—, —CF2O—, —OCF2—, —CF2S—, —SCF2—, —(CH2)n1—, —CF2CH2—, —CH2CF2—, —(CF2)n1—, —CH═CH—, —CF═CF—, —C≡C—, —CH═CH—, —COO—, —OCO—CH═CH—, CR0R00 or a single bond,
    • R0 and R00 each, independently of one another, denote H or alkyl having 1 to 12 C atoms,
    • Rx denotes P, P-Sp-, H, halogen, straight-chain, branched or cyclic alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH2 groups may each be replaced by —O—, —S—, —CO—, —CO—O—, —O—CO—, or —O—CO—O— in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may each be replaced by F, Cl, P or P-Sp-, an optionally substituted aryl or aryloxy group having 6 to 40 C atoms, or an optionally substituted heteroaryl or heteroaryloxy group having 2 to 40 C atoms,
    • m1 denotes 0, 1, 2, 3 or 4, and
    • n1 denotes 1, 2, 3 or 4,
      where at least one, preferably one, two or three, particularly preferably one or two, from the group RMa, RMb and the substituents L present denotes a group P or P-Sp- or contains at least one group P or P-Sp-.
  • Particularly preferred compounds of the formula M are those in which
    • RMa and RMb each, independently of one another, denote P, P-Sp-, H, F, Cl, Br, I, —CN, —NO2, —NCO, —NCS, —OCN, —SCN, SF5 or straight-chain or branched alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH2 groups may each be replaced, independently of one another, by —C(R0)═C(R00)—, —C≡C—, —N(R00)—, —O—, —S—, —CO—, —CO—O—, —O—CO—, or —O—CO—O— in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may each be replaced by F, Cl, Br, I, CN, P or P-Sp-, where at least one of the radicals RMa and RMb preferably denotes or contains a group P or P-Sp-,
    • AM1 and AM2 each, independently of one another, denote 1,4-phenylene, naphthalene-1,4-diyl, naphthalene-2,6-diyl, phenanthrene-2,7-diyl, anthracene-2,7-diyl, fluorene-2,7-diyl, coumarine, flavone, where, in addition, one or more CH groups in these groups may be replaced by N, cyclohexane-1,4-diyl, in which, in addition, one or more non-adjacent CH2 groups may be replaced by O and/or S, 1,4-cyclohexenylene, bicyclo[1.1.1]-pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, piperidine-1,4-diyl, decahydronaphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, indane-2,5-diyl or octahydro-4,7-methanoindane-2,5-diyl, where all these groups may be unsubstituted or mono- or polysubstituted by L,
    • L denotes P, P-Sp-, OH, CH2OH, F, Cl, Br, I, —CN, —NO2, —NCO, —NCS, —OCN, —SCN, —C(═O)N(Rx)2, —C(═O)Y1, —C(═O)Rx, —N(Rx)2, optionally substituted silyl, optionally substituted aryl having 6 to 20 C atoms, or straight-chain or branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 25 C atoms, in which, in addition, one or more H atoms may be replaced by F, Cl, P or P-Sp-,
    • P denotes a polymerizable group,
    • Y1 denotes halogen,
    • Rx denotes P, P-Sp-, H, halogen, straight-chain, branched or cyclic alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH2 groups may each be replaced by —O—, —S—, —CO—, —CO—O—, —O—CO—, or —O—CO—O— in such a way that 0 and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may each be replaced by F, Cl, P or P-Sp-, an optionally substituted aryl or aryloxy group having 6 to 40 C atoms, or an optionally substituted heteroaryl or heteroaryloxy group having 2 to 40 C atoms.
  • Very particular preference is given to compounds of the formula M in which one of RMa and RMb or both denote P or P-Sp-.
  • Suitable and preferred RMs for use in liquid-crystalline media and PS-VA displays or PSA displays according to the invention are selected, for example, from the following formulae:
  • Figure US20190218457A1-20190718-C00059
    Figure US20190218457A1-20190718-C00060
    Figure US20190218457A1-20190718-C00061
    Figure US20190218457A1-20190718-C00062
    Figure US20190218457A1-20190718-C00063
  • in which the individual radicals have the following meaning:
    • P1, P2 and P3 each, independently of one another, denote a polymerizable group, preferably having one of the meanings indicated above and below for P, particularly preferably an acrylate, methacrylate, fluoroacrylate, oxetane, vinyloxy or epoxy group,
    • Sp1, Sp2 and Spa each, independently of one another, denote a single bond or a spacer group, preferably having one of the meanings indicated above and below for Sp, and particularly preferably —(CH2)p1—, —(CH2)p1—O—, —(CH2)p1—CO—O— or —(CH2)p1—O—CO—O—, in which p1 is an integer from 1 to 12, and where in the last-mentioned groups the linking to the adjacent ring takes place via the O atom, where one of the radicals P1-Sp1-, P2-Sp2- and P3-Sp3- may also denote Raa,
    • Raa denotes H, F, Cl, CN or straight-chain or branched alkyl having 1 to 25 C atoms, in which, in addition, one or more non-adjacent CH2 groups may each be replaced, independently of one another, by —C(R0)═C(R00)—, —C≡C—, —N(R0)—, —O—, —S—, —CO—, —CO—O—, —O—CO—, or —O—CO—O— in such a way that O and/or S atoms are not linked directly to one another, and in which, in addition, one or more H atoms may each be replaced by F, Cl, CN or P1—Sp1-, particularly preferably straight-chain or branched, optionally mono- or polyfluorinated, alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl or alkylcarbonyloxy having 1 to 12 C atoms (where the alkenyl and alkynyl radicals have at least two and the branched radicals at least three C atoms),
    • R0, R00 each, independently of one another and on each occurrence identically or differently, denote H or alkyl having 1 to 12 C atoms,
    • ZM1 denotes —O—, —CO—, —C(RyRz)— or —CF2CF2—,
    • ZM2 and ZM3 each, independently of one another, denote —CO—O—, —O—CO—, —CH2O—, —OCH2—, —CF2O—, —OCF2— or —(CH2)n—, where n is 2, 3 or 4,
    • Ry and Rz each, independently of one another, denote H, F, CH3 or CF3,
    • L on each occurrence, identically or differently, denotes F, Cl, CN, or straight-chain or branched, optionally mono- or polyfluorinated, alkyl, alkoxy, alkenyl, alkynyl, alkylcarbonyl, alkoxycarbonyl or alkylcarbonyloxy having up to 12 C atoms, preferably F,
    • L′ and L″ each, independently of one another, denote H, F or Cl,
    • r denotes 0, 1, 2, 3 or 4,
    • s denotes 0, 1, 2 or 3,
    • t denotes 0, 1 or 2, and
    • x denotes 0 or 1.
  • Suitable polymerizable compounds are listed, for example, in Table D.
  • The liquid-crystalline media in accordance with the present application preferably comprise in total 0.1 to 10%, preferably 0.2 to 4.0%, particularly preferably 0.2 to 2.0%, of polymerizable compounds.
  • Particular preference is given to the polymerizable compounds of the formula M and of the formulae RM-1 to RM-121.
  • The mixtures according to the invention may furthermore comprise conventional additives, such as, for example, stabilizers, antioxidants, UV absorbers, nanoparticles, microparticles, etc.
  • The structure of the liquid-crystal displays according to the invention corresponds to the usual geometry, as described, for example, in EP-A 0 240 379, hereby incorporated by reference.
  • EXAMPLES
  • The following examples are intended to explain the invention without limiting it. Above and below, percent data denote percent by weight; all temperatures are indicated in degrees Celsius.
  • Throughout the patent application, 1,4-cyclohexylene rings and 1,4-phenylene rings are depicted as follows:
  • Figure US20190218457A1-20190718-C00064
  • The cyclohexylene rings are trans-1,4-cyclohexylene rings.
  • Throughout the patent application and in the working examples, the structures of the liquid-crystal compounds are indicated by means of acronyms. Unless indicated otherwise, the transformation into chemical formulae is carried out in accordance with Tables 1-3. All radicals CnH2n°1, CmH2m+1 and Cm′H2m′+1 or CnH2n and CmH2m are straight-chain alkyl radicals or alkylene radicals, in each case having n, m, m′ or z C atoms respectively. n, m, m′ and z each, independently of one another, denote 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12, preferably 1, 2, 3, 4, 5 or 6, and (O) denotes an oxygen atom or a single bond. In Table 1 the ring elements of the respective compound are coded, in Table 2 the bridging members are listed, and in Table 3 the meanings of the symbols for the left-hand or righthand side chains of the compounds are indicated.
  • TABLE 1
    Ring elements
    Figure US20190218457A1-20190718-C00065
    Figure US20190218457A1-20190718-C00066
    Figure US20190218457A1-20190718-C00067
    Figure US20190218457A1-20190718-C00068
    Figure US20190218457A1-20190718-C00069
    Figure US20190218457A1-20190718-C00070
    Figure US20190218457A1-20190718-C00071
    Figure US20190218457A1-20190718-C00072
    Figure US20190218457A1-20190718-C00073
    Figure US20190218457A1-20190718-C00074
    Figure US20190218457A1-20190718-C00075
    Figure US20190218457A1-20190718-C00076
    Figure US20190218457A1-20190718-C00077
    Figure US20190218457A1-20190718-C00078
    Figure US20190218457A1-20190718-C00079
    Figure US20190218457A1-20190718-C00080
    Figure US20190218457A1-20190718-C00081
    Figure US20190218457A1-20190718-C00082
    Figure US20190218457A1-20190718-C00083
    Figure US20190218457A1-20190718-C00084
    Figure US20190218457A1-20190718-C00085
    Figure US20190218457A1-20190718-C00086
    Figure US20190218457A1-20190718-C00087
    Figure US20190218457A1-20190718-C00088
    Figure US20190218457A1-20190718-C00089
  • TABLE 2
    Bridging members
    E —CH2CH2
    V —CH═CH—
    T —C≡C—
    W —CF2CF2
    Z —COO— ZI —OCO—
    O —CH2O— OI —OCH2
    Q —CF2O— QI —OCF2
  • TABLE 3
    Side chains
    Left-hand side chain Right-hand side chain
    n- CnH2n+1 -n —CnH2n+1
    nO- CnH2n+1—O— -On —O—CnH2n+1
    V- CH2═CH— -V —CH═CH2
    nV- CnH2n+1—CH═CH— -nV —CnH2n—CH═CH2
    Vn- CH2═CH—CnH2n -Vn —CH═CH—CnH2n+1
    nVm- CnH2n+1—CH═CH—CmH2m -nVm —CnH2n—CH═CH—CmH2m+1
    N- N≡C— -N —C≡N
    F- F— -F —F
    Cl- Cl— -Cl —Cl
    M- CFH2 -M —CFH2
    D- CF2H— -D —CF2H
    T- CF3 -T —CF3
    MO- CFH2O— -OM —OCFH2
    DO- CF2HO— -OD —OCF2H
    TO- CF3O— -OT —OCF3
    T- CF3 -T —CF3
    A- H—C≡C— -A —C≡C—H
  • Besides the compounds of the formulae IIA and/or IIB and/or IIC and the compounds of the formulae I1, I2 and EY, the mixtures according to the invention preferably comprise one or more of the compounds from Table A indicated below.
  • TABLE A
    The following abbreviations are used:
    (n, m, m′, z: each, independently of one another, 1, 2, 3, 4, 5 or 6;
    (O)CmH2m+1 means OCmH2m+1 or CmH2m+1)
    Figure US20190218457A1-20190718-C00090
    Figure US20190218457A1-20190718-C00091
    Figure US20190218457A1-20190718-C00092
    Figure US20190218457A1-20190718-C00093
    Figure US20190218457A1-20190718-C00094
    Figure US20190218457A1-20190718-C00095
    Figure US20190218457A1-20190718-C00096
    Figure US20190218457A1-20190718-C00097
    Figure US20190218457A1-20190718-C00098
    Figure US20190218457A1-20190718-C00099
    Figure US20190218457A1-20190718-C00100
    Figure US20190218457A1-20190718-C00101
    Figure US20190218457A1-20190718-C00102
    Figure US20190218457A1-20190718-C00103
    Figure US20190218457A1-20190718-C00104
    Figure US20190218457A1-20190718-C00105
    Figure US20190218457A1-20190718-C00106
    Figure US20190218457A1-20190718-C00107
    Figure US20190218457A1-20190718-C00108
    Figure US20190218457A1-20190718-C00109
    Figure US20190218457A1-20190718-C00110
    Figure US20190218457A1-20190718-C00111
    Figure US20190218457A1-20190718-C00112
    Figure US20190218457A1-20190718-C00113
    Figure US20190218457A1-20190718-C00114
    Figure US20190218457A1-20190718-C00115
    Figure US20190218457A1-20190718-C00116
    Figure US20190218457A1-20190718-C00117
    Figure US20190218457A1-20190718-C00118
    Figure US20190218457A1-20190718-C00119
    Figure US20190218457A1-20190718-C00120
    Figure US20190218457A1-20190718-C00121
    Figure US20190218457A1-20190718-C00122
    Figure US20190218457A1-20190718-C00123
    Figure US20190218457A1-20190718-C00124
    Figure US20190218457A1-20190718-C00125
    Figure US20190218457A1-20190718-C00126
    Figure US20190218457A1-20190718-C00127
    Figure US20190218457A1-20190718-C00128
    Figure US20190218457A1-20190718-C00129
    Figure US20190218457A1-20190718-C00130
    Figure US20190218457A1-20190718-C00131
    Figure US20190218457A1-20190718-C00132
    Figure US20190218457A1-20190718-C00133
    Figure US20190218457A1-20190718-C00134
    Figure US20190218457A1-20190718-C00135
    Figure US20190218457A1-20190718-C00136
    Figure US20190218457A1-20190718-C00137
    Figure US20190218457A1-20190718-C00138
    Figure US20190218457A1-20190718-C00139
    Figure US20190218457A1-20190718-C00140
    Figure US20190218457A1-20190718-C00141
    Figure US20190218457A1-20190718-C00142
    Figure US20190218457A1-20190718-C00143
    Figure US20190218457A1-20190718-C00144
    Figure US20190218457A1-20190718-C00145
    Figure US20190218457A1-20190718-C00146
    Figure US20190218457A1-20190718-C00147
    Figure US20190218457A1-20190718-C00148
    Figure US20190218457A1-20190718-C00149
    Figure US20190218457A1-20190718-C00150
    Figure US20190218457A1-20190718-C00151
    Figure US20190218457A1-20190718-C00152
    Figure US20190218457A1-20190718-C00153
    Figure US20190218457A1-20190718-C00154
    Figure US20190218457A1-20190718-C00155
    Figure US20190218457A1-20190718-C00156
    Figure US20190218457A1-20190718-C00157
    Figure US20190218457A1-20190718-C00158
    Figure US20190218457A1-20190718-C00159
    Figure US20190218457A1-20190718-C00160
    Figure US20190218457A1-20190718-C00161
    Figure US20190218457A1-20190718-C00162
    Figure US20190218457A1-20190718-C00163
    Figure US20190218457A1-20190718-C00164
    Figure US20190218457A1-20190718-C00165
    Figure US20190218457A1-20190718-C00166
    Figure US20190218457A1-20190718-C00167
    Figure US20190218457A1-20190718-C00168
    Figure US20190218457A1-20190718-C00169
    Figure US20190218457A1-20190718-C00170
    Figure US20190218457A1-20190718-C00171
    Figure US20190218457A1-20190718-C00172
    Figure US20190218457A1-20190718-C00173
    Figure US20190218457A1-20190718-C00174
    Figure US20190218457A1-20190718-C00175
    Figure US20190218457A1-20190718-C00176
    Figure US20190218457A1-20190718-C00177
    Figure US20190218457A1-20190718-C00178
    Figure US20190218457A1-20190718-C00179
    Figure US20190218457A1-20190718-C00180
    Figure US20190218457A1-20190718-C00181
    Figure US20190218457A1-20190718-C00182
    Figure US20190218457A1-20190718-C00183
    Figure US20190218457A1-20190718-C00184
    Figure US20190218457A1-20190718-C00185
    Figure US20190218457A1-20190718-C00186
    Figure US20190218457A1-20190718-C00187
    Figure US20190218457A1-20190718-C00188
    Figure US20190218457A1-20190718-C00189
    Figure US20190218457A1-20190718-C00190
    Figure US20190218457A1-20190718-C00191
    Figure US20190218457A1-20190718-C00192
    Figure US20190218457A1-20190718-C00193
    Figure US20190218457A1-20190718-C00194
    Figure US20190218457A1-20190718-C00195
    Figure US20190218457A1-20190718-C00196
    Figure US20190218457A1-20190718-C00197
    Figure US20190218457A1-20190718-C00198
    Figure US20190218457A1-20190718-C00199
    Figure US20190218457A1-20190718-C00200
    Figure US20190218457A1-20190718-C00201
    Figure US20190218457A1-20190718-C00202
    Figure US20190218457A1-20190718-C00203
    Figure US20190218457A1-20190718-C00204
    Figure US20190218457A1-20190718-C00205
    Figure US20190218457A1-20190718-C00206
    Figure US20190218457A1-20190718-C00207
    Figure US20190218457A1-20190718-C00208
    Figure US20190218457A1-20190718-C00209
    Figure US20190218457A1-20190718-C00210
    Figure US20190218457A1-20190718-C00211
    Figure US20190218457A1-20190718-C00212
    Figure US20190218457A1-20190718-C00213
    Figure US20190218457A1-20190718-C00214
    Figure US20190218457A1-20190718-C00215
    Figure US20190218457A1-20190718-C00216
    Figure US20190218457A1-20190718-C00217
    Figure US20190218457A1-20190718-C00218
    Figure US20190218457A1-20190718-C00219
    Figure US20190218457A1-20190718-C00220
    Figure US20190218457A1-20190718-C00221
    Figure US20190218457A1-20190718-C00222
    Figure US20190218457A1-20190718-C00223
    Figure US20190218457A1-20190718-C00224
    Figure US20190218457A1-20190718-C00225
    Figure US20190218457A1-20190718-C00226
  • The liquid-crystal mixtures which can be used in accordance with the invention are prepared in a manner which is conventional per se. In general, the desired amount of the components used in lesser amount is dissolved in the components making up the principal constituent, advantageously at elevated temperature. It is also possible to mix solutions of the components in an organic solvent, for example in acetone, chloroform or methanol, and to remove the solvent again, for example by distillation, after thorough mixing.
  • By means of suitable additives, the liquid-crystal phases according to the invention can be modified in such a way that they can be employed in any type of, for example, ECB, VAN, IPS, GH (guest-host) or ASM-VA (axially symmetric microdomain-vertically aligned)LCD display that has been disclosed to date.
  • The dielectrics may also comprise further additives known to the person skilled in the art and described in the literature, such as, for example, UV absorbers, antioxidants, nanoparticles and free-radical scavengers. For example, 0-15% of pleochroic dyes, stabilizers or chiral dopants may be added. Suitable stabilizers for the mixtures according to the invention are, in particular, those listed in Table B.
  • For example, 0-15% of pleochroic dyes, furthermore conductive salts, preferably ethyldimethyldodecylammonium 4-hexoxybenzoate, tetrabutylammonium tetraphenylboranate or complex salts of crown ethers (cf., for example, Haller et al., Mol. Cryst. Liq. Cryst., Volume 24, pages 249-258 (1973)), may be added in order to improve the conductivity or substances may be added in order to modify the dielectric anisotropy, the viscosity and/or the alignment of the nematic phases. Substances of this type are described, for example, in DE-A 22 09 127, 22 40 864, 23 21 632, 23 38 281, 24 50 088, 26 37 430 and 28 53 728.
  • TABLE B
    Table B shows possible dopants which are generally added to the mixtures
    according to the invention. The mixtures preferably comprise 0-10% by
    weight, in particular 0.01-5% by weight and particularly preferably 0.01-3%
    by weight of dopants. If the mixtures comprise only one dopant, is is em-
    ployed in amounts of 0.01-4% by weight, preferable 0.1-1.0% by weight.
    Figure US20190218457A1-20190718-C00227
    Figure US20190218457A1-20190718-C00228
    Figure US20190218457A1-20190718-C00229
    Figure US20190218457A1-20190718-C00230
    Figure US20190218457A1-20190718-C00231
    Figure US20190218457A1-20190718-C00232
    Figure US20190218457A1-20190718-C00233
    Figure US20190218457A1-20190718-C00234
    Figure US20190218457A1-20190718-C00235
    Figure US20190218457A1-20190718-C00236
    Figure US20190218457A1-20190718-C00237
    Figure US20190218457A1-20190718-C00238
    Figure US20190218457A1-20190718-C00239
  • TABLE C
    Stabilizers which can be added, for example, to the mixtures according to
    the invention in amounts of 0-10% by weight are shown below.
    Figure US20190218457A1-20190718-C00240
    Figure US20190218457A1-20190718-C00241
    Figure US20190218457A1-20190718-C00242
    Figure US20190218457A1-20190718-C00243
    Figure US20190218457A1-20190718-C00244
    Figure US20190218457A1-20190718-C00245
    Figure US20190218457A1-20190718-C00246
    Figure US20190218457A1-20190718-C00247
    Figure US20190218457A1-20190718-C00248
    Figure US20190218457A1-20190718-C00249
    Figure US20190218457A1-20190718-C00250
    Figure US20190218457A1-20190718-C00251
    Figure US20190218457A1-20190718-C00252
    Figure US20190218457A1-20190718-C00253
    Figure US20190218457A1-20190718-C00254
    Figure US20190218457A1-20190718-C00255
    Figure US20190218457A1-20190718-C00256
    Figure US20190218457A1-20190718-C00257
    Figure US20190218457A1-20190718-C00258
    Figure US20190218457A1-20190718-C00259
    Figure US20190218457A1-20190718-C00260
    Figure US20190218457A1-20190718-C00261
    Figure US20190218457A1-20190718-C00262
    Figure US20190218457A1-20190718-C00263
    Figure US20190218457A1-20190718-C00264
    Figure US20190218457A1-20190718-C00265
    Figure US20190218457A1-20190718-C00266
    Figure US20190218457A1-20190718-C00267
    Figure US20190218457A1-20190718-C00268
    Figure US20190218457A1-20190718-C00269
    Figure US20190218457A1-20190718-C00270
    Figure US20190218457A1-20190718-C00271
    Figure US20190218457A1-20190718-C00272
    Figure US20190218457A1-20190718-C00273
    Figure US20190218457A1-20190718-C00274
    Figure US20190218457A1-20190718-C00275
    Figure US20190218457A1-20190718-C00276
  • The medium according to the invention particularly preferably comprises Tinuvin® 770 (bis(2,2,6,6-tetramethyl-4-piperidyl) sebacate), preferably in amounts of 0.001-5% by weight, based on the liquid-crystalline medium.
  • TABLE D
    Table D shows example compounds which can preferably be used as reactive mesogenic compounds in the LC media in accordance with the
    present invention. If the mixtures according to the invention comprise one or more reactive compounds, they are preferably employed
    in amounts of 0.01-5% by weight. It may also be necessary to add an initiator or a mixture of two or more initiators for the
    polymerization. The initiator or initiator mixture is preferably added in amounts of 0.001-2% by weight, based on the mixture.
    A suitable initiator is, for example, Irgacure (BASF) or Irganox (BASF).
    Figure US20190218457A1-20190718-C00277
    RM-1 
    Figure US20190218457A1-20190718-C00278
    RM-2 
    Figure US20190218457A1-20190718-C00279
    RM-3 
    Figure US20190218457A1-20190718-C00280
    RM-4 
    Figure US20190218457A1-20190718-C00281
    RM-5 
    Figure US20190218457A1-20190718-C00282
    RM-6 
    Figure US20190218457A1-20190718-C00283
    RM-7 
    Figure US20190218457A1-20190718-C00284
    RM-8 
    Figure US20190218457A1-20190718-C00285
    RM-9 
    Figure US20190218457A1-20190718-C00286
    RM-10
    Figure US20190218457A1-20190718-C00287
    RM-11
    Figure US20190218457A1-20190718-C00288
    RM-12
    Figure US20190218457A1-20190718-C00289
    RM-13
    Figure US20190218457A1-20190718-C00290
    RM-14
    Figure US20190218457A1-20190718-C00291
    RM-15
    Figure US20190218457A1-20190718-C00292
    RM-16
    Figure US20190218457A1-20190718-C00293
    RM-17
    Figure US20190218457A1-20190718-C00294
    RM-18
    Figure US20190218457A1-20190718-C00295
    RM-19
    Figure US20190218457A1-20190718-C00296
    RM-20
    Figure US20190218457A1-20190718-C00297
    RM-21
    Figure US20190218457A1-20190718-C00298
    RM-22
    Figure US20190218457A1-20190718-C00299
    RM-23
    Figure US20190218457A1-20190718-C00300
    RM-24
    Figure US20190218457A1-20190718-C00301
    RM-25
    Figure US20190218457A1-20190718-C00302
    RM-26
    Figure US20190218457A1-20190718-C00303
    RM-27
    Figure US20190218457A1-20190718-C00304
    RM-28
    Figure US20190218457A1-20190718-C00305
    RM-29
    Figure US20190218457A1-20190718-C00306
    RM-30
    Figure US20190218457A1-20190718-C00307
    RM-31
    Figure US20190218457A1-20190718-C00308
    RM-32
    Figure US20190218457A1-20190718-C00309
    RM-33
    Figure US20190218457A1-20190718-C00310
    RM-34
    Figure US20190218457A1-20190718-C00311
    RM-35
    Figure US20190218457A1-20190718-C00312
    RM-36
    Figure US20190218457A1-20190718-C00313
    RM-37
    Figure US20190218457A1-20190718-C00314
    RM-38
    Figure US20190218457A1-20190718-C00315
    RM-39
    Figure US20190218457A1-20190718-C00316
    RM-40
    Figure US20190218457A1-20190718-C00317
    RM-41
    Figure US20190218457A1-20190718-C00318
    RM-42
    Figure US20190218457A1-20190718-C00319
    RM-43
    Figure US20190218457A1-20190718-C00320
    RM-44
    Figure US20190218457A1-20190718-C00321
    RM-45
    Figure US20190218457A1-20190718-C00322
    RM-46
    Figure US20190218457A1-20190718-C00323
    RM-47
    Figure US20190218457A1-20190718-C00324
    RM-48
    Figure US20190218457A1-20190718-C00325
    RM-49
    Figure US20190218457A1-20190718-C00326
    RM-50
    Figure US20190218457A1-20190718-C00327
    RM-51
    Figure US20190218457A1-20190718-C00328
    RM-52
    Figure US20190218457A1-20190718-C00329
    RM-53
    Figure US20190218457A1-20190718-C00330
    RM-54
    Figure US20190218457A1-20190718-C00331
    RM-55
    Figure US20190218457A1-20190718-C00332
    RM-56
    Figure US20190218457A1-20190718-C00333
    RM-57
    Figure US20190218457A1-20190718-C00334
    RM-58
    Figure US20190218457A1-20190718-C00335
    RM-59
    Figure US20190218457A1-20190718-C00336
    RM-60
    Figure US20190218457A1-20190718-C00337
    RM-61
    Figure US20190218457A1-20190718-C00338
    RM-62
    Figure US20190218457A1-20190718-C00339
    RM-63
    Figure US20190218457A1-20190718-C00340
    RM-64
    Figure US20190218457A1-20190718-C00341
    RM-65
    Figure US20190218457A1-20190718-C00342
    RM-66
    Figure US20190218457A1-20190718-C00343
    RM-67
    Figure US20190218457A1-20190718-C00344
    RM-68
    Figure US20190218457A1-20190718-C00345
    RM-69
    Figure US20190218457A1-20190718-C00346
    RM-70
    Figure US20190218457A1-20190718-C00347
    RM-71
    Figure US20190218457A1-20190718-C00348
    RM-72
    Figure US20190218457A1-20190718-C00349
    RM-73
    Figure US20190218457A1-20190718-C00350
    RM-74
    Figure US20190218457A1-20190718-C00351
    RM-75
    Figure US20190218457A1-20190718-C00352
    RM-76
    Figure US20190218457A1-20190718-C00353
    RM-77
    Figure US20190218457A1-20190718-C00354
    RM-78
    Figure US20190218457A1-20190718-C00355
    RM-79
    Figure US20190218457A1-20190718-C00356
    RM-80
    Figure US20190218457A1-20190718-C00357
    RM-81
    Figure US20190218457A1-20190718-C00358
    RM-82
    Figure US20190218457A1-20190718-C00359
    RM-83
    Figure US20190218457A1-20190718-C00360
    RM-84
    Figure US20190218457A1-20190718-C00361
    RM-85
    Figure US20190218457A1-20190718-C00362
    RM-86
    Figure US20190218457A1-20190718-C00363
    RM-87
    Figure US20190218457A1-20190718-C00364
    RM-88
    Figure US20190218457A1-20190718-C00365
    RM-89
    Figure US20190218457A1-20190718-C00366
    RM-90
    Figure US20190218457A1-20190718-C00367
    RM-91
    Figure US20190218457A1-20190718-C00368
    RM-92
    Figure US20190218457A1-20190718-C00369
    RM-93
    Figure US20190218457A1-20190718-C00370
    RM-94
    Figure US20190218457A1-20190718-C00371
    RM-95
    Figure US20190218457A1-20190718-C00372
    RM-96
    Figure US20190218457A1-20190718-C00373
    RM-97
    Figure US20190218457A1-20190718-C00374
    RM-98
    Figure US20190218457A1-20190718-C00375
    RM-99
    Figure US20190218457A1-20190718-C00376
    RM-100
    Figure US20190218457A1-20190718-C00377
    RM-101
    Figure US20190218457A1-20190718-C00378
    RM-102
    Figure US20190218457A1-20190718-C00379
    RM-103
    Figure US20190218457A1-20190718-C00380
    RM-104
    Figure US20190218457A1-20190718-C00381
    RM-105
    Figure US20190218457A1-20190718-C00382
    RM-106
    Figure US20190218457A1-20190718-C00383
    RM-107
    Figure US20190218457A1-20190718-C00384
    RM-108
    Figure US20190218457A1-20190718-C00385
    RM-109
    Figure US20190218457A1-20190718-C00386
    RM-110
    Figure US20190218457A1-20190718-C00387
    RM-111
    Figure US20190218457A1-20190718-C00388
    RM-112
    Figure US20190218457A1-20190718-C00389
    RM-113
    Figure US20190218457A1-20190718-C00390
    RM-114
    Figure US20190218457A1-20190718-C00391
    RM-115
    Figure US20190218457A1-20190718-C00392
    RM-116
    Figure US20190218457A1-20190718-C00393
    RM-117
    Figure US20190218457A1-20190718-C00394
    RM-118
    Figure US20190218457A1-20190718-C00395
    RM-119
    Figure US20190218457A1-20190718-C00396
    RM-120
    Figure US20190218457A1-20190718-C00397
    RM-121
  • In a preferred embodiment, the mixtures according to the invention comprise one or more polymerizable compounds, preferably selected from the polymerizable compounds of the formulae RM-1 to RM-121. Media of this type are suitable, in particular, for PS-FFS and PS-IPS applications. Of the reactive mesogens shown in Table D, compounds RM-1, RM-2, RM-3, RM-4, RM-5, RM-9, RM-17, RM-42, RM-48, RM-68, RM-87, RM-91, RM-98, RM-99 and RM-101 are particularly preferred.
  • The reactive mesogens or the polymerizable compounds of the formula M and of the formulae RM-1 to RM-121 are furthermore suitable as stabilizers. In this case, the polymerizable compounds are not polymerized, but instead are added to the liquid-crystalline medium in concentrations >1%.
  • Working Examples
  • The following examples are intended to explain the invention without limiting it. In the examples, m.p. denotes the melting point and C denotes the clearing point of a liquid-crystalline substance in degrees Celsius; boiling temperatures are denoted by b.p. Furthermore:
  • C denotes crystalline solid state, S denotes smectic phase (the index denotes the phase type), N denotes nematic state, Ch denotes cholesteric phase, I denotes isotropic phase, Tg denotes glass-transition temperature. The number between two symbols indicates the conversion temperature in degrees Celsius.
  • The host mixture used for determination of the optical anisotropy Δn of the compounds of the formula I is the commercial mixture ZLI-4792 (Merck KGaA). The dielectric anisotropy Δε is determined using commercial mixture ZLI-2857. The physical data of the compound to be investigated are obtained from the change in the dielectric constants of the host mixture after addition of the compound to be investigated and extrapolation to 100% of the compound employed. In general, 10% of the compound to be investigated are dissolved in the host mixture, depending on the solubility.
  • Unless indicated otherwise, parts or percent data denote parts by weight or percent by weight.
  • Above and below, the symbols and abbreviations have the following meanings:
    • Vo threshold voltage, capacitive [V] at 20° C.
    • Δn the optical anisotropy measured at 20° C. and 589 nm
    • Δε the dielectric anisotropy at 20° C. and 1 kHz
    • cl.p. clearing point [° C.]
    • K1 elastic constant, “splay” deformation at 20° C. [pN]
    • K3 elastic constant, “bend” deformation at 20° C. [pN]
    • γ1 rotational viscosity measured at 20° C. [mPa·s], determined by the rotation method in a magnetic field
    • LTS low-temperature stability (nematic phase), determined in test cells.
  • The display used for measurement of the threshold voltage has two plane-parallel outer plates at a separation of 20 μm and electrode layers with alignment layers comprising SE-1211 (Nissan Chemicals) on top on the insides of the outer plates, which effect a homeotropic alignment of the liquid crystals.
  • All concentrations in this application, unless explicitly indicated otherwise, relate to the corresponding mixture or mixture component. All physical properties are determined in accordance with “Merck Liquid Crystals, Physical Properties of Liquid Crystals”, status November 1997, Merck KGaA, Germany, and apply to a temperature of 20° C., unless explicitly indicated otherwise.
  • Example M1
  • CY-3-O2 12.00% Clearing point [° C.]: 74.0
    CY-3-O4 10.00% Δn [589 nm, 20° C.]: 0.1064
    CCY-3-O2 6.00% Δε [1 kHz, 20° C.]: −3.2
    CCY-4-O2 6.50% ε [1 kHz, 20° C.]: 3.8
    CCH-34 9.00% K1 [pN, 20° C.]: 13.7
    CCH-35 5.00% K3 [pN, 20° C.]: 13.6
    CCP-3-1 14.50% γ1 [mPa · s, 20° C.]: 119
    CCP-3-3 11.00% V0 [20° C., V]: 2.19
    PYP-2-3 9.00%
    PYP-2-4 8.00%
    Y-4O-O4 9.00%
  • Example P1
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M1 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00398
  • Example P2
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M1 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00399
  • Example P3
  • For the preparation of a PS-VA mixture, 99.8% of the mixture according to Example M1 is mixed with 0.2% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00400
  • Example P4
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M1 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00401
  • Example P5
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M1 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00402
  • Example P6
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M1 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00403
  • Example P7
  • For the preparation of a PS-VA mixture, 99.8% of the mixture according to Example M1 is mixed with 0.2% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00404
  • Example P8
  • For the preparation of a PS-VA mixture, 99.8% of the mixture according to Example M1 is mixed with 0.2% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00405
  • Example P9
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M1 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00406
  • Example M2
  • CY-3-O2 12.00% Clearing point [° C.]: 73.5
    CY-3-O4 10.00% Δn [589 nm, 20° C.]: 0.1065
    CCY-3-O2 6.00% Δε [1 kHz, 20° C.]: −3.3
    CCY-4-O2 5.50% ε [1 kHz, 20° C.]: 3.8
    CCH-34 8.50% K1 [pN, 20° C.]: 13.9
    CCH-35 5.00% K3 [pN, 20° C.]: 13.9
    CCP-3-1 15.00% γ1 [mPa · s, 20° C.]: 119
    CCP-3-3 11.50% V0 [20° C., V]: 2.18
    PYP-2-3 5.50%
    PYP-2-4 5.00%
    PP-1-3 2.00%
    PGIY-2-O4 5.00%
    Y-4O-O4 9.00%
  • Example P10
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M2 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00407
  • Example P11
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M2 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00408
  • Example P12
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M2 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00409
  • Example P13
  • For the preparation of a PS-VA mixture, 99.8% of the mixture according to Example M2 is mixed with 0.2% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00410
  • Example P14
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M2 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00411
  • Example P15
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M2 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00412
  • Example P16
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M2 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00413
  • Example M3
  • CY-3-O2 11.00% Clearing point [° C.]: 75.0
    CY-3-O4 10.00% Δn [589 nm, 20° C.]: 0.1077
    CCY-3-O2 6.00% Δε [1 kHz, 20° C.]: −3.3
    CCY-4-O2 6.00% ε [1 kHz, 20° C.]: 3.8
    CCH-34 8.50% K1 [pN, 20° C.]: 14.3
    CCH-35 5.00% K3 [pN, 20° C.]: 14.1
    CCP-3-1 15.00% γ1 [mPa · s, 20° C.]: 122
    CCP-3-3 11.50% V0 [20° C., V]: 2.20
    PYP-2-3 6.00%
    PYP-2-4 5.00%
    PP-1-2V1 2.00%
    PGIY-2-O4 5.00%
    Y-4O-O4 9.00%
  • Example P17
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M3 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00414
  • Example P18
  • For the preparation of a PS-VA mixture, 99.8% of the mixture according to Example M3 is mixed with 0.2% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00415
  • Example P19
  • For the preparation of a PS-VA mixture, 99.8% of the mixture according to Example M3 is mixed with 0.2% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00416
  • Example P20
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M3 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00417
  • Example P21
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M3 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00418
  • Example M4
  • PY-3-O2 10.50% Clearing point [° C.]: 75.0
    CY-3-O2 7.00% Δn [589 nm, 20° C.]: 0.1081
    CCY-3-O1 3.50% Δε [1 kHz, 20° C.]: −3.4
    CCY-3-O2 11.00% ε [1 kHz, 20° C.]: 3.9
    CPY-3-O2 7.00% K1 [pN, 20° C.]: 16.5
    CCH-34 9.00% K3 [pN, 20° C.]: 16.5
    CCH-35 5.00% γ1 [mPa · s, 20° C.]: 113
    CC-3-V1 7.50% V0 [20° C., V]: 2.35
    CCP-3-1 5.00%
    CCP-3-3 13.00%
    PP-1-3 8.00%
    PGIY-2-O4 5.00%
    Y-4O-O4 8.50%
  • Example M5
  • CC-3-V1 9.00% Clearing point [° C.]: 74.5
    CCH-34 10.00% Δn [589 nm, 20° C.]: 0.0983
    CCH-35 5.00% Δε [1 kHz, 20° C.]: −3.6
    CCP-3-1 15.50% ε [1 kHz, 20° C.]: 3.8
    CCP-3-3 5.00% K1 [pN, 20° C.]: 14.9
    CCY-3-O2 8.00% K3 [pN, 20° C.]: 16.7
    CCY-3-O1 3.50% γ1 [mPa · s, 20° C.]: 112
    CPY-3-O2 10.00% V0 [20° C., V]: 2.28
    CY-3-O2 15.50%
    PY-3-O2 11.50%
    Y-4O-O4 7.00%
  • Example P22
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M5 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00419
  • Example P23
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M5 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00420
  • Example P24
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M5 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00421
  • Example P25
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M5 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00422
  • Example P26
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M5 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00423
  • Example P27
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M5 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00424
  • Example M6
  • BCH-32 2.50% Clearing point [° C.]: 75.0
    CC-3-V1 9.00% Δn [589 nm, 20° C.]: 0.0978
    CCH-3O1 6.00% Δε [1 kHz, 20° C.]: −3.5
    CCH-34 10.00% ε [1 kHz, 20° C.]: 3.8
    CCH-35 5.00% K1 [pN, 20° C.]: 14.6
    CCP-3-1 13.50% K3 [pN, 20° C.]: 16.1
    CCY-3-O1 3.50% γ1 [mPa · s, 20° C.]: 107
    CCY-3-O2 11.00% V0 [20° C., V]: 2.28
    CPY-3-O2 11.00%
    CY-3-O2 10.00%
    PY-3-O2 11.50%
    Y-4O-O4 7.00%
  • Example M7
  • PY-3-O2 2.00% Clearing point [° C.]: 76.0
    CY-3-O2 4.50% Δn [589 nm, 20° C.]: 0.1061
    CCY-3-O1 4.50% Δε [1 kHz, 20° C.]: −3.4
    CCY-3-O2 11.00% ε [1 kHz, 20° C.]: 3.8
    CPY-3-O2 4.50% K1 [pN, 20° C.]: 16.5
    CCH-34 10.00% K3 [pN, 20° C.]: 16.5
    CCH-35 5.00% γ1 [mPa · s, 20° C.]: 108
    CC-3-V1 7.50% V0 [20° C., V]: 2.34
    PP-1-2V1 7.50%
    CCP-3-1 14.00%
    CCP-3-3 8.50%
    PGIY-2-O4 5.00%
    Y-4O-O4 12.00%
    B-2O-O5 4.00%
  • Example P28
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M7 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00425
  • Example P29
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M7 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00426
  • Example P30
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M7 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00427
  • Example P31
  • For the preparation of a PS-VA mixture, 99.8% of the mixture according to Example M7 is mixed with 0.2% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00428
  • Example P32
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M7 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00429
  • Example P33
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M7 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00430
  • Example P34
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M7 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00431
  • Example M8
  • CY-3-O2 11.00% Clearing point [° C.]: 74.0
    CY-3-O4 4.00% Δn [589 nm, 20° C.]: 0.1084
    CCY-3-O2 6.00% Δε [1 kHz, 20° C.]: −3.3
    CCY-4-O2 6.00% ε [1 kHz, 20° C.]: 3.9
    CCH-34 10.00% K1 [pN, 20° C.]: 14.8
    CCH-35 5.00% K3 [pN, 20° C.]: 14.4
    CCP-3-1 16.00% γ1 [mPa · s, 20° C.]: 115
    CCP-3-3 12.00% V0 [20° C., V]: 2.20
    PYP-2-3 7.00%
    PP-1-3 5.00%
    PGIY-2-O4 5.00%
    Y-4O-O4 9.00%
    B-2O-O5 4.00%
  • Example M9
  • CC-3-V1 4.00% Clearing point [° C.]: 74.0
    CY-3-O2 11.00% Δn [589 nm, 20° C.]: 0.1102
    CCY-3-O2 10.00% Δε [1 kHz, 20° C.]: −2.9
    CCH-34 10.00% ε [1 kHz, 20° C.]: 3.7
    CCH-35 4.00% K1 [pN, 20° C.]: 15.3
    CCP-3-1 16.00% K3 [pN, 20° C.]: 15.1
    CCP-3-3 13.00% γ1 [mPa · s, 20° C.]: 105
    PYP-2-3 7.00% V0 [20° C., V]: 2.42
    PP-1-3 5.00%
    PP-1-4 2.00%
    PGIY-2-O4 5.00%
    Y-4O-O4 9.00%
    B-2O-O5 4.00%
  • Example P35
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M9 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00432
  • Example P36
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M9 is mixed with 0.3% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00433
  • Example P37
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M9 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00434
  • Example P38
  • For the preparation of a PS-VA mixture, 99.75% of the mixture according to Example M9 is mixed with 0.25% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00435
  • Example P39
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M9 is mixed with 0.299% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00436
  • and 0.001% of Irganox-1076 (BASF). Example P40
  • For the preparation of a PS-VA mixture, 99.7% of the mixture according to Example M9 is mixed with 0.299% of the polymerizable compound of the formula
  • Figure US20190218457A1-20190718-C00437
  • and 0.001% of Irganox-1076 (BASF).
  • The mixtures according to Examples P39 and P40 are preferably suitable for PS-VA applications, in particular 2D and 3D TV applications.
  • The above-mentioned mixture examples for PS-VA applications are of course also suitable for PS-IPS and PS-FFS applications.
  • In order to improve the reliability, the mixtures according to Examples M1 to M9 and P1 to P40 may additionally be stabilized with one or two stabilizers selected from the group of compounds a) to h) mentioned below, where the stabilizer is in each case added in amounts of 0.01-0.04%, based on the mixture.
  • Figure US20190218457A1-20190718-C00438
    Figure US20190218457A1-20190718-C00439
  • Example M10
  • For the preparation of a stabilized VA mixture, 99.999% of the mixture according to Example M1 is mixed with 0.001% of the compound of the formula
  • Figure US20190218457A1-20190718-C00440
  • Example M11
  • For the preparation of a stabilized VA mixture, 99.99% of the mixture according to Example M1 is mixed with 0.01% of the compound of the formula
  • Figure US20190218457A1-20190718-C00441
  • Example M12
  • For the preparation of a stabilized VA mixture, 99.999% of the mixture according to Example M7 is mixed with 0.001% of the compound of the formula
  • Figure US20190218457A1-20190718-C00442
  • The entire disclosures of all applications, patents and publications, cited herein and of corresponding European Application No. DE 102016004834.4, filed Apr. 11, 2016 are incorporated by reference herein.
  • Without further elaboration, it is believed that one skilled in the art can, using the preceding description, utilize the present invention to its fullest extent. The preceding preferred specific embodiments are, therefore, to be construed as merely illustrative, and not limitative of the remainder of the disclosure in any way whatsoever.
  • The preceding examples can be repeated with similar success by substituting the generically or specifically described reactants and/or operating conditions of this invention for those used in the preceding examples.
  • From the foregoing description, one skilled in the art can easily ascertain the essential characteristics of this invention and, without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.

Claims (25)

1. A liquid-crystalline medium comprising:
a compound of the formula I1 and/or a compound of the formula I2
Figure US20190218457A1-20190718-C00443
one or more compounds of formula EY
Figure US20190218457A1-20190718-C00444
in which the individual radicals each, independently of one another, and identically or differently on each occurrence, have one of the following meanings:
R1 and R1* denote H, an alkyl or alkenyl radical having up to 15 C atoms which is unsubstituted, monosubstituted by CN or CF3 or at least monosubstituted by halogen, where, in addition, one or more CH2 groups in these radicals may each be replaced by —O—, —S—,
Figure US20190218457A1-20190718-C00445
 —C≡C—, —CF2O—, —OCF2—, —OC—O— or —O—CO— in such a way that O atoms are not linked directly to one another, or a cycloalkyl ring having 3 to 6 C atoms,
L1 and L2 denote F, Cl, CF3 or CHF2,
with the proviso that the liquid-crystalline medium does not comprise a compound of the formula I3,
Figure US20190218457A1-20190718-C00446
and
one or more compounds selected from the group of the compounds of formulae BC, CR, PH-1, PH-2, BF-1, BF-2, BS-1 and BS-2
Figure US20190218457A1-20190718-C00447
in which
RB1, RB2, RCR1, RCR2, R1, and R2 each, independently of one another, denote H, an alkyl or alkenyl radical having up to 15 C atoms which is unsubstituted, monosubstituted by CN or CF3 or at least monosubstituted by halogen, where, in addition, one or more CH2 groups in these radicals may each be replaced by —O—, —S—,
Figure US20190218457A1-20190718-C00448
 —C≡C—, —CF2O—, —OCF2—, —OC—O— or —O—CO— in such a way that O atoms are not linked directly to one another,
c denotes 0, 1 or 2, and
d denotes 1 or 2.
2. A liquid-crystalline medium according to claim 1, wherein said one or more compounds of formula EY are selected from the group of compounds of the following formulae:
Figure US20190218457A1-20190718-C00449
Figure US20190218457A1-20190718-C00450
Figure US20190218457A1-20190718-C00451
3. A liquid-crystalline medium according to claim 1, further comprising one or more compounds selected from the group of compounds of formulae IIA, IIB and IIC,
Figure US20190218457A1-20190718-C00452
in which
R2A, R2B and R2C each, independently of one another, denote H, an alkyl or alkenyl radical having up to 15 C atoms which is unsubstituted, monosubstituted by CN or CF3 or at least monosubstituted by halogen, where, in addition, one or more CH2 groups in these radicals may each be replaced by —O—, —S—,
Figure US20190218457A1-20190718-C00453
 —C≡C—, —CF2O—, OCF2, —OC—O— or —O—CO— in such a way that O atoms are not linked directly to one another,
L1-4 each, independently of one another, denote F or Cl,
Z2 and Z2′ each, independently of one another, denote a single bond, —CH2CH2—, —CH═CH—, —CF2O—, —OCF2—, —CH2O—, —OCH2—, —COO—, —OCO—, —C2F4, —CF═CF—, or —CH═CHCH2O—,
p denotes 1 or 2,
q denotes 0 or 1, and
v denotes an integer from 1 to 6.
4. A liquid-crystalline medium according to claim 1, wherein said medium additionally comprises one or more compounds of formula III,
Figure US20190218457A1-20190718-C00454
in which
R31 and R32 each, independently of one another, denote a straight-chain alkyl, alkoxyalkyl or alkoxy radical having up to 12 C atoms,
Figure US20190218457A1-20190718-C00455
denotes
Figure US20190218457A1-20190718-C00456
and
Z3 denotes a single bond, —CH2CH2—, —CH═CH—, —CF2O—, —OCF2—, —CH2O—, —OCH2—, —COO—, —OCO—, —C2F4—, —C4H9—, or —CF═CF—.
5. A liquid-crystalline medium according to claim 1, wherein said medium additionally comprises one or more terphenyls of formulae T-1 to T-21,
Figure US20190218457A1-20190718-C00457
Figure US20190218457A1-20190718-C00458
Figure US20190218457A1-20190718-C00459
in which
R denotes a straight-chain alkyl or alkoxy radical having 1-7 C atoms or a straight-chain alkenyl radical having 2-7 C atoms,
m denotes 0, 1, 2, 3, 4, 5 or 6,
n denotes 0, 1, 2, 3 or 4, and
(O) denotes an oxygen atom or a single bond.
6. A liquid-crystalline medium according to claim 1, wherein said medium additionally comprises one or more compounds of formulae O-1 to O-17,
Figure US20190218457A1-20190718-C00460
Figure US20190218457A1-20190718-C00461
in which
R1 and R2 each, independently of one another, denote H, an alkyl or alkenyl radical having up to 15 C atoms which is unsubstituted, monosubstituted by CN or CF3 or at least monosubstituted by halogen, where, in addition, one or more CH2 groups in these radicals may each be replaced by —O—, —S—,
Figure US20190218457A1-20190718-C00462
 —C≡C—, —CF2O—, —OCF2—, —OC—O— or —O—CO— in such a way that O atoms are not linked directly to one another, and
the compounds of the formula O-17 are not identical with the compounds of the formulae I1 and I2.
7. A liquid-crystalline medium according claim 1, wherein said medium additionally comprises one or more indane compounds of formula In,
Figure US20190218457A1-20190718-C00463
in which
R11, R12, R13 denote a straight-chain alkyl, alkoxy, alkoxyalkyl or alkenyl radical having 1-6 or 2-6 C atoms respectively,
R12 and R13 additionally may also denote halogen,
Figure US20190218457A1-20190718-C00464
denotes
Figure US20190218457A1-20190718-C00465
i denotes 0, 1 or 2.
8. A liquid-crystalline medium according to claim 1, wherein said medium additionally comprises one or more biphenyls selected from formulae B-1a, B-2a, B-2b, and B-2c:
Figure US20190218457A1-20190718-C00466
in which alkyl* denotes an alkyl radical having 1-6 C atoms.
9. A liquid-crystalline medium according to claim 1, wherein said medium additionally comprises one or more compounds selected from the group of the following compounds:
Figure US20190218457A1-20190718-C00467
10. A liquid-crystalline medium according to claim 1, wherein said medium additionally comprises one or more compounds selected from the group of the following compounds:
Figure US20190218457A1-20190718-C00468
11. A liquid-crystalline medium according to claim 1, wherein said medium comprises one or more compounds selected from the group of the compounds of formulae BF-1, BF-2, BS-1 and BS-2,
Figure US20190218457A1-20190718-C00469
in which
R1, and R2 each, independently of one another, denote H, an alkyl or alkenyl radical having up to 15 C atoms which is unsubstituted, monosubstituted by CN or CH3 or at least monosubstituted by halogen, where, in addition, one or more CH2 groups in these radicals may each be replaced by —O—, —S—,
Figure US20190218457A1-20190718-C00470
 —C≡C—, —CF2O—, —OCF2—, —OC—O— or —O—CO— in such a way that O atoms are not linked directly to one another,
c denotes 0, 1 or 2, and
d denotes 1 or 2.
12. A liquid-crystalline medium according to claim 1, wherein the proportion of compounds of the formulae I1 and I2 in the mixture as a whole is 5-30% by weight.
13. A liquid-crystalline medium according to claim 1, wherein the proportion of compounds of the formulae I1 and 12 in the mixture is ≥3% by weight.
14. A liquid-crystalline medium according to claim 1, wherein the proportion of compounds of the formula EY in the mixture as a whole is 3-20% by weight.
15. A liquid-crystalline medium according to claim 1, wherein the proportion of compounds of the formula EY in the mixture is ≥2% by weight.
16. A liquid-crystalline medium according to claim 1, wherein the proportion of compounds of the formulae I1, I2 and EY in the mixture as a whole is 10-35% by weight.
17. A liquid-crystalline medium according to claim 1, wherein said medium further comprises at least one polymerizable compound.
18. A liquid-crystalline medium according to claim 1, wherein said medium further comprises one or more additives selected from the group consisting of free-radical scavengers, antioxidants and UV stabilizers.
19. A process for the preparation of a liquid-crystalline medium according claim 1, said process comprising:
mixing a compound of the formulae I1 and I2 with at least one compound of the formula EY and one or more compounds of formulae BC, CR, PH-1, PH-2, BF-1, BF-2, BS-1 and BS-2, and optionally adding one or more additives and optionally at least one polymerizable compound.
20. (canceled)
21. An electro-optical display having active-matrix addressing, wherein said display contains, as dielectric, a liquid-crystalline medium according to claim 1.
22. An electro-optical display according to claim 21, wherein said display is a VA, PSA, PS-VA, PM-VA, SS-VA, PALC, IPS, PS-IPS, FFS or PS-FFS display.
23. A liquid-crystalline medium according to claim 3, wherein said medium contains one or more compounds of formula IIB.
24. A liquid-crystalline medium according to claim 1, wherein R1 and R2 each, independently of one another, denote alkyl, alkoxy, alkenyl or alkenyloxy having 1 to 6 or 2 to 6 C atoms respectively.
25. A liquid-crystalline medium according to claim 11, wherein R1 and R2 each, independently of one another, denote alkyl, alkoxy, alkenyl or alkenyloxy having 1 to 6 or 2 to 6 C atoms respectively.
US16/364,475 2016-04-21 2019-03-26 Liquid-crystalline medium Abandoned US20190218457A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/364,475 US20190218457A1 (en) 2016-04-21 2019-03-26 Liquid-crystalline medium

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102016004834 2016-04-21
DE102016004834.4 2016-04-21
US15/492,431 US11453824B2 (en) 2016-04-21 2017-04-20 Liquid-crystalline medium
US16/364,475 US20190218457A1 (en) 2016-04-21 2019-03-26 Liquid-crystalline medium

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/492,431 Division US11453824B2 (en) 2016-04-21 2017-04-20 Liquid-crystalline medium

Publications (1)

Publication Number Publication Date
US20190218457A1 true US20190218457A1 (en) 2019-07-18

Family

ID=58549044

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/492,431 Active US11453824B2 (en) 2016-04-21 2017-04-20 Liquid-crystalline medium
US16/364,475 Abandoned US20190218457A1 (en) 2016-04-21 2019-03-26 Liquid-crystalline medium

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US15/492,431 Active US11453824B2 (en) 2016-04-21 2017-04-20 Liquid-crystalline medium

Country Status (7)

Country Link
US (2) US11453824B2 (en)
EP (1) EP3235894B1 (en)
JP (2) JP2018009143A (en)
KR (3) KR20170120505A (en)
CN (2) CN107304360A (en)
DE (1) DE102017002925A1 (en)
TW (2) TWI796296B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112018006224T5 (en) * 2017-12-08 2020-09-24 Merck Patent Gmbh Liquid crystalline medium
JP6575735B1 (en) * 2017-12-15 2019-09-18 Dic株式会社 Liquid crystal composition and liquid crystal display element
DE102019003615A1 (en) 2018-06-21 2019-12-24 Merck Patent Gmbh LIQUID CRYSTAL MEDIUM
JP2020200428A (en) * 2019-06-13 2020-12-17 Dic株式会社 Polymerizable compound-containing liquid crystal composition and liquid crystal display element
CN113072954A (en) * 2021-03-24 2021-07-06 北京八亿时空液晶科技股份有限公司 Polymerizable compound-containing liquid crystal composition and application thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012434A (en) 1971-08-07 1977-03-15 Merck Patent Gesellschaft Mit Beschrankter Haftung Nematic compounds and mixtures
BE795849A (en) 1972-02-26 1973-08-23 Merck Patent Gmbh MODIFIED NEMATIC PHASES
US3814700A (en) 1972-08-03 1974-06-04 Ibm Method for controllably varying the electrical properties of nematic liquids and dopants therefor
US3953491A (en) 1972-08-19 1976-04-27 Merck Patent Gesellschaft Mit Beschraenkter Haftung Phenyl esters of 4-benzoyloxybenzoic acid
US4136053A (en) 1974-10-22 1979-01-23 Merck Patent Gesellschaft Mit Beschankter Haftung Biphenyl esters and liquid crystalline mixtures comprising them
DE2450088A1 (en) 1974-10-22 1976-04-29 Merck Patent Gmbh Liquid crystalline dielectrics for electronic components - contg biphenylyl carboxylic acid phenyl ester or benzoic acid biphenylyl ester components
JPS52114482A (en) 1976-03-18 1977-09-26 Merck Patent Gmbh Liquid cryatal dielectric substance and manufacture
DE2637430A1 (en) 1976-08-20 1978-02-23 Merck Patent Gmbh Heterocyclic diaza cpd. in liquid crystalline dielectric - for electrooptical registration devices, giving stable orientation parallel to electrode surfaces
DE2853728A1 (en) 1978-12-13 1980-07-17 Merck Patent Gmbh LIQUID CRYSTALLINE CARBONIC ACID ESTER, METHOD FOR THE PRODUCTION THEREOF, ITS CONTAINING DIELECTRICS AND ELECTRO-OPTICAL DISPLAY ELEMENT
FR2595157B1 (en) 1986-02-28 1988-04-29 Commissariat Energie Atomique CELL WITH A DOUBLE LAYER OF LIQUID CRYSTAL, USING THE ELECTRICALLY CONTROLLED BIREFRINGENCE EFFECT AND METHOD FOR MANUFACTURING A UNIAXIC NEGATIVE ANISOTROPY ANISOTROPY MEDIUM FOR USE IN THIS CELL
US6781665B2 (en) 2002-02-04 2004-08-24 Fujitsu Display Technologies Corporation Liquid crystal display and method of manufacturing the same
DE50306559D1 (en) 2002-07-06 2007-04-05 Merck Patent Gmbh Liquid crystalline medium
DE102006010641A1 (en) * 2005-03-24 2006-09-28 Merck Patent Gmbh Liquid crystalline medium, useful in electrooptical indicator, comprises a mixture of fluorinated phenanthrene compounds
EP1958999B1 (en) * 2007-02-13 2012-07-11 Merck Patent GmbH Liquid crystalline medium
DE102011009691A1 (en) 2010-02-09 2011-08-11 Merck Patent GmbH, 64293 Liquid crystalline medium
KR20220134791A (en) * 2011-03-29 2022-10-05 메르크 파텐트 게엠베하 Liquid-crystalline medium
DE102012024126A1 (en) * 2011-12-20 2013-06-20 Merck Patent Gmbh Liquid crystalline medium
US9809747B2 (en) 2012-10-12 2017-11-07 Dic Corporation Liquid crystal composition and liquid crystal display element using the same
TWI623609B (en) * 2013-03-06 2018-05-11 Dainippon Ink & Chemicals Nematic liquid crystal composition and liquid crystal display element using same
KR102252761B1 (en) * 2013-08-02 2021-05-18 메르크 파텐트 게엠베하 Liquid-crystalline medium
KR20150070027A (en) * 2013-12-16 2015-06-24 메르크 파텐트 게엠베하 Liquid-crystalline medium
DE102013021279A1 (en) 2013-12-18 2015-06-18 Merck Patent Gmbh Process for cleaning a liquid crystal mixture
WO2015139827A1 (en) 2014-03-17 2015-09-24 Merck Patent Gmbh Liquid crystal medium
EP2921545B1 (en) 2014-03-21 2019-08-21 Merck Patent GmbH Polymerisable compounds and the use thereof in liquid-crystal displays
EP2937401B8 (en) * 2014-04-22 2017-08-02 Merck Patent GmbH Liquid crystalline medium
EP3421569B1 (en) 2014-06-17 2020-03-11 Merck Patent GmbH Liquid crystalline medium
EP2985334B1 (en) * 2014-08-15 2018-06-20 Merck Patent GmbH Liquid-crystalline medium
EP2990459B1 (en) * 2014-08-25 2017-04-26 Merck Patent GmbH Polymerisable compounds and the use thereof in liquid-crystal displays
US20160090533A1 (en) 2014-09-17 2016-03-31 Merck Patent Gmbh Liquid-crystalline medium
WO2016146245A1 (en) 2015-03-13 2016-09-22 Merck Patent Gmbh Liquid-crystal medium
EP3130650B1 (en) * 2015-08-10 2018-07-04 Merck Patent GmbH Liquid-crystalline medium

Also Published As

Publication number Publication date
US11453824B2 (en) 2022-09-27
EP3235894A3 (en) 2017-11-08
JP2022101586A (en) 2022-07-06
US20170306232A1 (en) 2017-10-26
EP3235894A2 (en) 2017-10-25
TW202346547A (en) 2023-12-01
KR20230082004A (en) 2023-06-08
CN107304360A (en) 2017-10-31
KR20170120505A (en) 2017-10-31
TWI796296B (en) 2023-03-21
TW201739905A (en) 2017-11-16
DE102017002925A1 (en) 2017-10-26
KR20230078974A (en) 2023-06-05
EP3235894B1 (en) 2020-12-23
JP2018009143A (en) 2018-01-18
CN116478701A (en) 2023-07-25

Similar Documents

Publication Publication Date Title
US11214736B2 (en) Liquid-crystalline medium
US9580653B2 (en) Liquid-crystalline medium
JP7446723B2 (en) liquid crystal medium
US10934487B2 (en) Liquid crystalline medium
US9234136B2 (en) Liquid-crystalline medium
US9951274B2 (en) Liquid-crystalline medium
US10208251B2 (en) Liquid-crystalline medium
US9714381B2 (en) Liquid-crystalline medium
US9777216B2 (en) Liquid crystalline medium
US10131841B2 (en) Liquid-crystalline medium
US8877092B2 (en) Liquid-crystalline medium
US11441073B2 (en) Liquid-crystalline medium
US20160319194A1 (en) Liquid crystalline medium
US8399073B2 (en) Liquid-crystal medium
US11453824B2 (en) Liquid-crystalline medium
US20170044436A1 (en) Liquid-crystalline medium
US20180265784A1 (en) Liquid-crystalline medium

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION